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ABSTRACT 
Sepsis, the exaggerated systemic inflammatory response to 
infection, often leads to multi-organ failure (MOF) and death. Skeletal 
muscle function is often profoundly affected, with patients requiring 
prolonged ventilatory support and rehabilitation. The pathophysiology 
underlying MOF and muscle failure in sepsis remains poorly understood. 
Recent evidence points to mitochondrial dysfunction and cellular 
energetic down-regulation, related in part to excess generation of reactive 
oxygen and nitrogen species (ROS). Substrate oxidation by the 
mitochondrial respiratory chain generates a proton gradient across the 
inner mitochondrial membrane that is coupled to ATP production. 
Mitochondrial uncoupling proteins (UCPs) may reduce mitochondrial ROS 
formation, though at the expense of oxidative phsophorylation. Notably, 
UCP3 is up-regulated in sepsis but its physiological role is unknown. I 
therefore hypothesized that muscle dysfunction in sepsis has a 
mitochondrial aetiology and increased UCP3 expression offers a 
protective role. I investigated this in a fluid-resuscitated murine model of 
faecal peritonitis/MOF (optimized and characterized during this project). I 
used Ucp3(-/-) mice to explore the role of this uncoupling protein in sepsis.  
I observed a profound hypothermic and hypometabolic response 
early in the course of severe sepsis. This was accompanied by 
respiratory muscle dysfunction and fatigue, as well as a decrease in 
mitochondrial proton-motive force (measured using novel live-cell 2-
photon confocal imaging techniques in freshly isolated ex-vivo diaphragm 
muscles). By contrast, the mitochondrial proton-motive force was 
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unaffected in septic Ucp3(-/-) mice, but no difference was seen in whole-
body metabolic response or respiratory muscle fatigue. Furthermore, 
proton leak and substrate utilization of mitochondria isolated from whole 
body skeletal muscle from wild-type septic mice were unchanged, though 
superoxide production was higher. These findings suggest that up-
regulation of UCP3 in sepsis has no whole- body metabolic or functional 
consequence in skeletal muscle. The low global oxygen consumption and 
diaphragm mitochondrial proton-motive force suggest a reduced cellular 
metabolic demand in the septic mice. 
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CHAPTER 1. INTRODUCTION 
1.1 Sepsis definition and epidemiology 
 The Systemic Inflammatory Response Syndrome (SIRS) is the 
result of an exaggerated whole body response to an exogenous insult 
such as trauma, ischaemia/reperfusion or toxins. When infection is the 
underlying aetiology it is termed sepsis (Bone, Balk et al. 1992). SIRS is 
defined by the presence of at least two of the following: 
1. Body temperature >38°C or <36°C 
2. Heart rate >90 beats/minute 
3. Hyperventilation (resp. rate >20/min or PaCO2 of <4.25 kPa) 
4. White blood cell count of >12,000 or <4,000 cells/litre 
 Following the International Sepsis Definition Conference in 2001, 
the above criteria were widened to include hyperglycaemia in the 
absence of diabetes, altered mental status, hyperlactataemia and 
decreased capillary refill (Levy, Fink et al. 2003). Severe sepsis is 
associated with organ dysfunction whereas septic shock is severe sepsis 
associated with persisting hypotension despite appropriate volume 
resuscitation.    
 Sepsis carries a high mortality and morbidity. Of 343,860 UK 
intensive care unit admissions from 1996-2004, 27% fufilled severe 
sepsis criteria within 24 h of admission and their mortality rate was 45% 
(Harrison, Welch et al. 2006). The incidence of sepsis in the US was 
reported to be 153 cases per 100,000 with a hospital mortality rate of 
28.5% and an associated cost of $22,100 per case (Angus, Linde-Zwirble 
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et al. 2001). Another US study showed a three-fold increase in incidence 
over two decades (Martin, Mannino et al. 2003). Despite medical 
advances, up to 50% of patients still die as a result of severe sepsis 
(Vincent, Abraham et al. 2002). Although the demographic is changing 
with more elderly and immunosuppressed patients being treated, our 
incomplete appreciation of the underlying mechanisms of the disease is 
also a major contributor to our relative lack of progress. 
 
1.2 The pathophysiology of sepsis and multi-organ failure 
 Inflammatory-immune changes occurring during sepsis are both 
complex and time-dependent (reviewed by (Hotchkiss and Karl 2003)). 
While the early phase is characterized by an increase in pro-inflammatory 
mediators (a “cytokine storm”) with increased production of reactive 
oxygen (ROS) and nitrogen species (RNS) (Biswal and Remick 2007), 
this is replaced within hours to days by an overall immunosuppressive 
phenotype and an increased susceptibility to nosocomial infection 
(Osuchowski, Welch et al. 2006; Monneret, Venet et al. 2008; Hotchkiss, 
Coopersmith et al. 2009). Immune cells show reduced responsiveness to 
antigen (Ward, Casserly et al. 2008; Adib-Conquy and Cavaillon 2009) 
while apoptosis is increased in lymphocytes but delayed in neutrophils 
(Hotchkiss, Swanson et al. 1999).  
Concurrent changes are seen in macro- and microcirculatory 
function, in activation of coagulation and fibrinolytic pathways, and in 
hormonal, bioenergetic and metabolic pathways. Remarkably, apart from 
an influx of inflammatory cells and increased tissue oedema, there is little 
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structural damage to affected organs with minimal cell death (Hotchkiss, 
Swanson et al. 1999). In a systematic review of histopathological 
changes found in patients and animals with septic acute kidney injury, 
acute tubular necrosis was a rare event (Langenberg, Bagshaw et al. 
2008). Notably, organ dysfunction tends to recover within days-to-weeks 
in survivors, even in organs that are generally poorly regenerative such 
as the kidney (Noble, MacKirdy et al. 2001; Bagshaw, Uchino et al. 
2007). It has been postulated that the organism enters into a state of 
“cellular energy dormancy” as an evolutionary adaptation to enhance the 
likelihood of survival from an otherwise overwhelming external insult 
(Singer, De Santis et al. 2004).   
 
Figure 1.1 Simplified diagram of proposed mechanisms of cellular 
dysfunction in sepsis. Although the arrows point in one direction, in reality 
the processes identified above are likely to be more interdependent. 
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1.2.1 Tissue pO2 in septic multi-organ failure 
Patients with severe sepsis often present with lactataemia and 
metabolic acidosis suggestive of poor tissue perfusion (De Backer 2003; 
Dellinger, Levy et al. 2008). However, direct measurements of tissue pO2 
(tPo2) in skeletal muscle of septic patients (Boekstegers, Weidenhöfer et 
al. 1994), and in gut (VanderMeer, Wang et al. 1995) and bladder 
epithelium (Rosser, Stidwill et al. 1995) in animal models reported 
elevated levels of tPo2. As tPo2 represents the dynamic equilibrium 
between local supply and utilization of oxygen, this suggests a relative 
availability but non-utilization of oxygen. Importantly, these data challenge 
traditionally held view that multi-organ failure in sepsis is simply due to 
tissue hypoxia (Protti and Singer 2006). 
Other data support this hypothesis. For example, peripheral limb 
oxygen consumption measured during a short-lived vascular occlusion 
was reduced in septic patients compared to age-matched healthy 
volunteers or patients with localized infection (De Blasi, Palmisani et al. 
2005; Pareznik, Knezevic et al. 2006). This correlated with sepsis severity 
but improved as the patients recovered. Recovery on restoration of blood 
flow was also impaired, suggesting a concurrent problem with tissue flow 
and vascular recruitment (Payen, Luengo et al. 2009).  
My host lab recently reported changes in tPo2 from peripheral 
(skeletal muscle and bladder epithelium) and central (kidney and liver) 
organs in a long-term fluid-resuscitated model of faecal peritonitis (Dyson, 
Bezemer et al. 2011). Early (6 hour) falls in muscle, renal and hepatic 
tPo2 were followed by normalization at 24h, despite worsening clinical 
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and biochemical status including hyperlactataemia. Indeed, the 
significance of serum lactate levels as a marker of global tissue hypoxia 
and anaerobic respiration in sepsis has been questioned (James, 
Luchette et al. 1999). High lactate levels can occur as a result of 
accelerated aerobic glycolysis coupled to skeletal muscle Na+/K+ ATPase 
activity stimulated by high levels of endogenous epinephrine in septic 
shock (Levy, Gibot et al. 2005).  
The role of tissue hypoxia in amplifying the systemic inflammatory 
response should not however be discounted as early haemodynamic 
interventions to correct tissue perfusion resulted in significantly reduced 
mortality (Rivers, Nguyen et al. 2001). Later attempts at correction, once 
the patient was already in established organ failure, offered either no 
benefit (Gattinoni, Brazzi et al. 1995) or even harm (Hayes, Timmins et al. 
1994).  Tissue hypoxia in itself may trigger a shutdown of cellular 
metabolism that synergizes with direct inhibition (or damage) of 
mitochondrial respiration (Frost, Wang et al. 2005).  This may explain why 
sepsis-induced changes in cellular metabolism may not be promptly 
reversible (Kern and Shoemaker 2002; Poeze, Greve et al. 2005).   
 
1.2.2 Whole body metabolism and temperature in sepsis 
The data presented above suggest reduced cellular metabolism in 
sepsis. In terms of whole body metabolism, patients with sepsis and 
septic shock show an average 10-15% increase in resting energy 
expenditure compared to healthy, age-matched normal subjects 
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(Chioléro, Revelly et al. 1997; Miles 2006). Values are approximately 
twice normal in uncomplicated sepsis fall to normal values in septic shock 
but rise significantly during recovery (61±22% above normal) (Kreymann, 
Grosser et al. 1993). Similar findings have been reported in neonatal and 
paediatric sepsis where a predominantly hypometabolic response was 
observed in those with septic shock and multi-organ failure (Briassoulis, 
Venkataraman et al. 2010; Feferbaum, Leone et al. 2010). The 
hypermetabolic pattern only emerged during the recovery phase. 
Importantly, core body temperature changes of 1ºC results in 10% 
changes in VO2 (Manthous, Hall et al. 1995; Bruder, Raynal et al. 1998). 
Ten percent of adult septic patients present with hypothermia and this is 
independently associated with a two-fold increase in mortality (Clemmer, 
Fisher et al. 1992; Arons, Wheeler et al. 1999). Cellular metabolism of 
such patients will likely be significantly lower, although Kreymann et al 
(Kreymann, Grosser et al. 1993) could find no correlation between VO2 
and temperature. This hints at a more complex relationship between 
temperature and VO2 in sepsis.  
Animal studies confirm hypothermic and hypometabolic responses 
in young animals (Garrett-Cox, Pierro et al. 2003). However, adult rats 
injected with intraperitoneal endotoxin (LPS) show variable temperature 
responses depending on the dose and type of LPS injected (Dogan, 
Ataoglu et al. 2000). In general, a biphasic pattern of early hypothermia 
followed by normothermia or pyrexia is observed. The extent of the initial 
hypothermia is dose-dependent and associated with falls in blood 
pressure (Romanovsky, Shido et al. 1996; Dogan, Ataoglu et al. 2000).  
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Mice however exhibit an opposite pattern when challenged with 
LPS. Following an early rise in temperature, they become hypothermic 
depending on LPS dose, ambient temperature and the degree of stress 
suffered (Leon 2004; Rudaya, Steiner et al. 2005).  
Caecal ligation and puncture (CLP) in mice is associated with 
hypothermia, reductions in VO2 and a fall in respiratory exchange ratio 
from 0.85 to 0.7, favouring lipid metabolism (Valencia, Sarma et al. 2005). 
The severity of these changes were not predictive of survival. In another 
study, intra-peritoneal implantation of fibrin clot inoculated with 
Staphylococcus aureus in mice resulted in a one-third reduction in VO2  
(Haden, Suliman et al. 2007); clinical recovery occurred within 3-7 days 
and was preceded by mitochondrial biogenesis (discussed later). 
The hypothermic response in septic animal models was originally 
thought to be circulatory in origin. However, this appears to be a 
regulated response affected by ambient temperature and the degree of 
stress placed on the animal (reviewed by (Leon 2004)). This may offer 
survival benefits (Habicht 1981; Romanovsky, Shido et al. 1997). Pyrexia 
and hypothermia may thus be two distinct strategies of fighting systemic 
inflammation offering benefit under differing conditions (Romanovsky and 
Székely 1998). Fever may support host defence mechanisms against the 
invading organism, whereas hypothermia may act as a defensive 
mechanism that support the host’s vital functions by reducing metabolic 
demands.  
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1.3 Mitochondrial physiology and sepsis 
 Mitochondria utilise >90% of the body’s total oxygen consumption. 
This is predominantly for generating adenosine 5'-triphosphate (ATP), the 
crucial energy currency for cellular processes. The host lab has shown in 
septic patients, animal models and in vitro models that mitochondrial 
dysfunction is closely associated with multi-organ failure (Brealey, Brand 
et al. 2002; Brealey, Karyampudi et al. 2004; Frost, Wang et al. 2005). 
Patients who eventually died had significantly lower muscle ATP levels 
(Brealey, Brand et al. 2002), a finding replicated in liver and muscle in a 
3-day rodent faecal peritonitis model (Brealey, Karyampudi et al. 2004). 
Inhibition of mitochondrial respiration by increased production of nitric 
oxide and its derivative peroxynitrite is implicated in the causation of this 
bioenergetic failure (Brown and Borutaite 2004; Frost, Wang et al. 2005) .  
 
1.3.1 Cellular and mitochondrial metabolism   
Mitochondrial ATP production begins with cytosolic metabolism of 
high-energy glucose and fatty acid molecules. Glycolysis results in the 
net production of 2 ATP molecules per glucose molecule, and the 
formation of pyruvate which is taken up and metabolized within 
mitochondria to produce a further 30 or so ATP molecules. Pyruvate and 
fatty acyl CoA enter the citric acid cycle and generate the high energy 
reduced co-enzymes, nicotinamide adenine dinucleotide (NADH) and 
flavin adenine dinucleotide (FADH2). These molecules act as reducing 
equivalents that donate electrons to the electron transport chain. As the 
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electrons pass down the chain, energy is captured in the form of a proton 
gradient which is then utilised to generate ATP (Fig 1.2). 
 
Figure 1.2 Glycolysis and lipolysis provide substrate to the citric acid 
(Krebs’) cycle. Through NADH and FAD, electrons are donated to the 
electron transport chain resulting in significantly larger production of ATP. 
 
1.3.1.1 The electron transport chain and ATP synthesis 
The electron transport chain is composed of five enzyme 
complexes held within the inner mitochondrial membrane. Compared with 
the highly porous outer membrane, the inner membrane is tightly bound 
with transporter molecules shuttling molecules and solutes across the 
membrane (Fig 1.3). The first four respiratory chain complexes are 
involved in substrate oxidation and formation of an energy gradient, while 
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the fifth (ATP synthase) utilises this gradient to generate ATP.  
NADH and FADH2 produced by the Krebs’ cycle donate electrons 
to complexes I (NADH dehydrogenase) and II (succinate 
dehydrogenase), respectively. Oxidized NAD+ and FAD then re-enter the 
cycle. Donated electrons are passed to complexes III (cytochrome bc1) 
and IV (cytochrome c oxidase) where molecular oxygen acts as the 
terminal oxygen acceptor. During this process, protons are pumped out of 
the mitochondrial matrix into the intermembrane space by complexes I, III 
and IV, generating a proton gradient across the membrane. This charge 
difference, the mitochondrial transmembrane potential (Δψm), normally 
rests at -150 to -180mV (Fig. 1.3). It serves as a store of energy for the 
various energetic processes that take place across the inner membrane 
(e.g. ATP production and various transport processes). 
In isolation, complex V (the F1F0-ATP synthase) acts as an 
ATPase, breaking down ATP to transport protons out of the mitochondrial 
matrix. However, when in situ within the charged inner membrane of the 
mitochondria, it works in reverse, driven by the energy stored in the form 
of the Δψm to generate ATP (Nicholls and Ferguson 2002). ATP 
production by complex V therefore depends upon the magnitude of Δψm 
and the ability of the respiratory chain to maintain Δψm (Fig 1.4). This was 
the basis of the chemiosmotic theory developed by Peter Mitchell in 1961 
for which he received the Nobel prize (MITCHELL 1961).  
Under ischaemic/anoxic conditions, the respiratory chain cannot 
maintain the protonmotive force. The resultant thermodynamic conditions 
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favour reverse function of the ATP synthase (Jennings, Reimer et al. 
1991; Nicholls and Ferguson 2002) which now switches to its native 
ATPase function, consuming ATP and pumping protons out of the 
mitochondrial matrix. This maintains Δψm at the expense of ATP depletion 
(reviewed by (Duchen 2004)). The rapidly falling ATP levels lead to 
energy depletion within the cell, however the maintained Δψm means that 
mitochondrial integrity is retained, as mitochondrial depolarisation may be 
a trigger for apoptosis.  
 
 
Figure 1.3 Diagram showing the internal structure of mitochondria (left 
panel) with the convoluted inner mitochondrial membrane housing the 
respiratory chain (right panel). The first four complexes of the respiratory 
chain are involved in substrate oxidation with reduction of oxygen to 
water. Protons pumped out of the mitochondrial matrix during this 
process generate a proton gradient (transmembrane potential-Δψm) used 
by complex V (ATP synthase) to produce ATP. Some protons leak 
directly back into the mitochondrial matrix, either passively or through 
specialized proteins (uncoupling proteins), bypassing ATP synthesis.  
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1.3.1.2 Mitochondrial proton leak 
The mitochondrial protonmotive force (Δψm) is mainly used to 
convert ADP to ATP. This process of coupled oxidative phosphorylation is 
incomplete as some protons leak back into the mitochondrial matrix 
bypassing ATP synthesis and generating heat instead. This “proton leak”, 
increases in magnitude exponentially as the transmembrane potential 
rises. It is split into two components (reviewed by (Jastroch, Divakaruni et 
al. 2010)): 
1. Basal proton leak: This constitutes ~20% of basal metabolic rate 
(BMR) of hepatocytes, and up to 50% in rat skeletal muscle (Noble, 
MacKirdy et al. 2001). It depends on the phospholipid constitution of 
the lipid bilayer and the abundance of anion carrier proteins, e.g. 
adenine nucleotide translocase (ANT) and uncoupling protein-1 (UCP-
1) within the inner mitochondrial membrane. ANT is normally 
responsible for shuttling ATP and ADP across this membrane.  
2. Inducible proton leak: This is mediated by activation of ANT and 
UCP-1 proteins by fatty acids and reactive alkenals such as 
hydroxynonenal (HNE). UCP-1 (also known as thermogenin) is 
expressed abundantly in brown fat mitochondria and is responsible for 
adrenergic-stimulated mitochondrial uncoupling during non-shivering 
thermogenesis (Nicholls 2001). UCP-1 catalyzes a regulated passage 
of protons back into the mitochondrial matrix but generates heat rather 
than capturing their energy in the form of ATP or other chemical 
processes. The functions of uncoupling proteins -2 and -3 are more 
controversial and will be discussed later. 
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Uncoupling of oxidative phosphorylation has been studied in 
obesity and diabetes. Chemical uncoupling agents such as 2,4-
dinitrophenol (DNP) have been used for weight control (Harper, Dickinson 
et al. 2001). However, following a series of deaths and serious illnesses, 
this drug was withdrawn in 1938. Clearly, mitochondrial proton leak has a 
significant impact upon both cellular and whole animal metabolism, 
though its role in pathophysiological states is less clearly defined. 
 
1.3.1.3 Mitochondria and reactive oxygen species (ROS) 
Mitochondria are the major source (90%) of cellular reactive 
oxygen species (ROS) production within the body (reviews by (Balaban, 
Nemoto et al. 2005) and (Murphy 2009)). At low concentrations, 
mitochondrial ROS serve a redox signaling role to the rest of the cell 
(Dröge 2002). However, at higher concentrations, these highly reactive 
species cause inhibition or direct damage to proteins and other cellular 
components. They are implicated in a variety of pathological processes 
including ischaemia-reperfusion injury (Li and Jackson 2002), sepsis and 
ageing (Balaban, Nemoto et al. 2005). ROS are produced predominantly 
as superoxide (O2·-) at complexes I and III under reducing conditions 
when the mitochondrial matrix NADH/NAD+ ratio is high, or when Δψm is 
high with a low flux through the respiratory chain. Conversely, when 
mitochondria are making ATP at high electron flux, the rate of ROS 
production is much lower (Votyakova and Reynolds 2001; St-Pierre, 
Buckingham et al. 2002). Cytoplasmic and mitochondrial superoxide 
dismutase convert O2·- to hydrogen peroxide (H2O2) that is then 
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deactivated by anti-oxidant mechanisms (e.g. catalase and glutathione 
peroxidases) that are also present in both mitochondrial matrix and 
cytoplasm.  Figure 1.4 shows the major sites of mitochondrial ROS 
production. 
 
Sepsis is associated with increased ROS production (Nethery, 
DiMarco et al. 1999; Zhang, Slutsky et al. 2000), depletion of intracellular 
anti-oxidant stores (Brealey, Brand et al. 2002; Brealey, Karyampudi et al. 
2004), and increased markers of oxidative stress (Andrades, Ritter et al. 
2009; Supinski, Murphy et al. 2009). ROS production in sepsis arises 
from both activation of leukocytes (Zhang, Slutsky et al. 2000) and from 
mitochondria (Llesuy, Evelson et al. 1994; Taylor, Ghio et al. 1995; 
Kozlov, Staniek et al. 2006; Supinski and Callahan 2006). 
Mitochondrially-targetted anti-oxidant treatments such as pegylated 
superoxide dismutase (PEG-SOD) and MitoQ have shown improvements 
in cellular and mitochondrial dysfunction in sepsis (Supinski and Callahan 
2006; Supinski, Murphy et al. 2009), (Lowes, Thottakam et al. 2008). 
Non-specific anti-oxidants such as N-acetylcysteine (NAC) and 
desferrioxamine have also resulted in improved cellular and mitochondrial 
function (Zapelini, Rezin et al. 2008).  Thus, low level mitochondrial ROS 
production serves a signaling role in health whereas excess production, 
as seen in sepsis, can damage mitochondria and other cellular structures. 
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Figure 1.4 Mitochondrial superoxide production occurs predominantly at 
complexes I and III. At high transmembrane potentials, when electron flux 
down the respiratory chain slows, the unpaired electrons more readily 
interact with O2, resulting in increased superoxide production. 
Mitochondrial depolarisation has the opposite effect as electron flux 
increases. Superoxide dismutase (SOD) converts superoxide to H2O2. 
Mitochondrial and cellular anti-oxidant mechanisms such as catalase and 
glutathione neutralize reactive species and limit cellular damage.  
 
1.3.2 Nitric oxide, sepsis and mitochondrial physiology 
In sepsis, a major source of excess NO production is increased 
expression of the inducible isoform of nitric oxide synthase (iNOS) 
(Boczkowski, Lanone et al. 1996; Carreras, Franco et al. 2004). Nitric 
oxide (NO) reacts with O2 to form NO2 and N2O3, or with superoxide (O2·-) 
to form peroxynitrite (ONOO-) and other highly reactive nitrogen species 
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(RNS). These can oxidize, nitrate, nitrosate and nitrosylate amines and 
thiols. NO and its metabolites contribute towards vascular hyporeactivity 
(Levy, Collin et al. 2010), cardiac dysfunction (Rudiger and Singer 2007), 
skeletal muscle contractile dysfunction and mitochondrial inhibition. High 
nitrite and nitrate levels (metabolites of NO) are observed in human 
sepsis and animal models, and are associated with reduced levels of ATP 
and oxidative phsophorylation (Callahan, Stofan et al. 2001; Brealey, 
Brand et al. 2002; Brealey, Karyampudi et al. 2004).  
 Effects of NO on mitochondrial function include (Brown and 
Borutaite 2001):  
1. Inhibition of the respiratory chain 
2. Stimulation of reactive oxygen and nitrogen species production  
3. Induction of permeability transition 
NO is a potent inhibitor of cytochrome oxidase (complex IV of the 
respiratory chain) by competing directly with O2. The reversibility of this 
inhibition has led to speculation that NO may regulate oxidative 
metabolism (Brown 2001). More prolonged exposure to NO leads to 
formation of other RNS, in particular ONOO-, that can irreversibly inhibit 
respiratory chain complexes, particularly complex I. Inhibition of the 
respiratory chain increased production of ROS, which can further react 
with NO to form even more ONOO- (Poderoso, Carreras et al. 1996). This 
vicious spiral may eventually lead to cell dysfunction and even death. 
Decreased mitochondrial respiratory rates and higher ROS production 
have been reported in skeletal muscle of rodent models of endotoxaemia 
and caecal ligation/puncture (Boczkowski, Lisdero et al. 1999; Callahan, 
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Stofan et al. 2001). 
A large multi-centre randomized controlled trial of a NOS inhibitor 
in sepsis was stopped early due to excess mortality in the treatment 
groups (López, Lorente et al. 2004). However, the NOS inhibitor used 
was non-selective, affecting all NOS isoforms and likely to have even 
blocked the adaptive consequences of increased NO synthesis (Cobb 
1999; Hotchkiss, Swanson et al. 1999). 
 
1.3.3 Mitochondrial calcium accumulation 
Transport of large molecules and cations such as Ca2+ across the 
inner mitochondrial membrane also rely on the transmembrane potential. 
Accumulation of mitochondrial calcium ([Ca2+]m) during normal 
physiological cell signaling represents an important physiological stimulus 
that enhances ATP synthesis (McCormack and Denton 1993).  
Cellular processes associated with increased energy demand (e.g. 
muscular contraction or neuronal activity) are driven by increased 
cytosolic [Ca2+]. This signal is also propagated to mitochondria, leading to 
increased ATP generation. However, if combined with oxidative stress, a 
high [Ca2+]m can become a major pathological stimulus, opening the 
mitochondrial permeability transition pore (mPTP), releasing cytochrome 
c and promoting apoptotic or necrotic cell death (Duchen 2000; Brookes, 
Yoon et al. 2004; Duchen 2004). In conjunction with NO, Ca2+ enhances 
cytochrome c dissociation from the mitochondrial inner membrane, 
blocking the respiratory chain at complex III and stimulating ROS 
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production (Jacobson and Duchen 2004). Mitochondrial Ca2+ uptake 
depends on both cytosolic [Ca2+] and Δψm. A decrease in potential may 
thus decrease mitochondrial Ca2+ uptake. Surprisingly, in view of its 
importance in signaling, energy regulation and cell death, this has not 
been previously assessed in sepsis. While intracellular Ca2+ 
dysregulation has been described in septic models (reviewed by (Rudiger 
and Singer 2007) and (Sayeed 2000)), alterations in [Ca2+]m remain to be 
investigated. 
 
1.3.4 Mitochondrial dysfunction in sepsis 
  Mitochondrial dysfunction can affect cellular function through the 
following processes (Callahan and Supinski 2009): 
1. Reduced availability of high-energy phosphates, leading to a 
cellular metabolic crisis 
2. Increased production of reactive oxygen species, resulting in 
damage to proteins and organelles (covered in 1.3.1.3); 
3. Caspase activation and induction of apoptotic pathways by 
release of cytochrome C. In sepsis this is likely to be more 
important in immune cells and the gut epithelium (Ayala, 
Wesche-Soldato et al. 2007), than in other organs where little 
to no apoptosis is seen (Hotchkiss, Swanson et al. 1999; 
Langenberg, Bagshaw et al. 2008). 
 The current knowledge base of sepsis-induced mitochondrial 
dysfunction based around the various components of oxidative 
phosphorylation is described below. 
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1.3.4.1 Electron transport chain dysfunction 
 Varying degrees of respiratory chain dysfunction have been 
reported in human and animal studies of sepsis. This is dependent upon 
sepsis severity, duration of illness and the organ studied (Brealey and 
Singer 2003). Few human studies have been reported. The largest series 
to date, studying patients with septic shock (compared to age-matched 
control patients undergoing elective hip surgery), showed reduced 
maximal activity of complex I in homogenates of skeletal muscle biopsied 
within 24 hours of ICU admission (Brealey, Brand et al. 2002). This 
inhibiton was greater in patients who eventually died, and was associated 
with higher nitrite/nitrate levels and lower tissue ATP levels. Of note, 
complex IV activity was increased. In another study, healthy volunteers 
given bacterial LPS underwent muscle biopsy at 2 and 4 hours 
(Fredriksson, Fläring et al. 2009). The investigators noted increased 
mitochondrial citrate synthase and complex I activities, implying that 
mitochondrial activity may be increased during the early stages of sepsis, 
although no changes in ATP or other high-energy phosphate levels were 
seen. 
Most animal models of sepsis are based on rodents treated with 
LPS or by caecal ligation and puncture, with varying degrees of fluid 
resuscitation and organ dysfunction (Fredriksson and Rooyackers 2007). 
The results generally show similar findings of reduced respiratory chain 
activity that correlates with clinical severity (Crouser, Julian et al. 2002; 
Brealey, Karyampudi et al. 2004; Callahan and Supinski 2005). Addition 
of succinate to increase flux through complex II of the respiratory chain, 
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bypassing complex I inhibition, restored respiratory function in skeletal 
muscle taken from a rat model of sepsis (Protti, Carré et al. 2007).  
Crouser et al (Crouser, Julian et al. 2002) showed reduced state 3 
respiration (ADP dependent respiratory rate) in liver mitochondria isolated 
from LPS-treated, fluid resuscitated cats. Similar findings were found in 
rats injected with intraperitoneal LPS, where reduction in diaphragm 
muscle mitochondrial oxygen consumption was noted along with a 
selective depletion of mitochondrial complexes I, III, IV and V subunits 
(Callahan and Supinski 2005).  My host lab reported a fall in 
mitochondrial respiratory proteins and transcript levels in patients with 
severe sepsis, that correlated with reduced functional capacity of the 
mitochondria (Carré, Orban et al. 2010).  
  
1.3.4.2 Mitochondrial transmembrane potential (Δψm) 
 Compared to healthy controls, a higher percentage of monocytes 
isolated from severely septic patients had depolarised mitochondria Adrie 
et al (Adrie, Bachelet et al. 2001). This percentage was greater in 
eventual non-survivors. Hepatocytes isolated from LPS-treated rats also 
had a lower Δψm than controls (Růzicka, Skobisová et al. 2005).The 
percentage of viable hepatocytes isolated from the septic rats was also 
20% lower than controls, implying a higher degree of fragility of cells.  
 
1.3.4.3 ATP Synthase defect 
 ATP synthase protein abundance decreased after six hours in 
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hearts isolated from rats treated with endotoxin (Robichaud, Lalu et al. 
2009). This was accompanied by decreased activity of enzymes of the 
glycolytic and β-oxidation pathways. Callahan et al (Callahan and 
Supinski 2005) also reported reductions in the beta subunit of ATP 
synthase in skeletal muscle of LPS-treated rats. 
  
1.3.4.4 Uncoupled respiration 
 Porta et al (Porta, Takala et al. 2006) found increased state 4 
(ADP-independent) mitochondrial respiration in liver mitochondria isolated 
from endotoxic pigs. Kidney and skeletal muscle mitochondria were 
unaffected, signifying differing responses between organs. Brain 
homogenates from mice who underwent caecal ligation and puncture 
showed higher state 4 respiration compared to sham controls (d'Avila, 
Santiago et al. 2008), with reduced respiratory control ratios (ratio of state 
3:state 4 respiratory rates where lower ratios signify higher uncoupled 
respiration), and reduced ADP:O ratios (amount of ATP synthetized per 
unit oxygen consumption). They suggested that reduced coupling 
efficiency of oxidative phosphorylation was a potential mechanism 
underlying septic encephalopathy. 
While most of the above studies have focussed upon mitochondrial 
function in whole tissue homogenate or isolated mitochondria, few have 
been performed in living intact cells or tissues isolated from septic 
humans or animals. Mitochondria do not work in isolation (Fig. 1.5). ATP 
production is governed by demands of energy-requiring cellular 
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processes, and by availability of substrate and oxygen. Regulatory 
mechanisms (involving, e.g., NO and intracellular Ca2+) alter and perhaps 
fine-tune their function. Most physiological studies of isolated 
mitochondria define their maximal functional capacity. This may not be 
necessary for “normal” cellular function, but may potentially be needed 
when extra strain is placed upon the cell, requiring an increase in 
metabolic flux. Therefore, a major aim of my project was to develop 
techniques to study cellular and mitochondrial physiology (e.g. Δψm) in 
living cells and tissues isolated from sick septic animals, and to correlate 
these with function in isolated mitochondria.   
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Figure 1.5 Metabolic supply/demand regulation of mitochondrial function. 
Mitochondrial respiration is governed by the amount of available 
substrate and the demand for high energy phosphate. Regulatory 
mechanisms alter mitochondrial respiration while gene expression affects 
the abundance of mitochondrial protein. Ca2+ increases flux through the 
respiratory chain by stimulating the dehydrogenases of the Krebs’ cycle, 
whereas NO inhibits respiration at complexes I and IV.   
 
1.4 The uncoupling proteins (UCPs) 
These anion membrane transporter molecules are located within 
the mitochondrial inner membrane. While UCP-1 function is generally well 
understood, the (patho)physiological roles of UCP-2 and -3 remain 
uncertain. UCP-2 and -3 both share 57% homology with UCP-1, and are 
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found in cells and tissues that are crucial for energy expenditure, 
metabolism and immune function (Pecqueur, Alves-Guerra et al. 2001). 
UCP-2 is widely expressed in most mammalian tissues (Fleury, Neverova 
et al. 1997), while UCP-3 is predominantly expressed in fat, skeletal and 
cardiac muscle (Boss, Samec et al. 1997). Expression of UCPs increases 
with starvation and sepsis, and are associated with conditions such as 
insulin resistance in diabetes and atherosclerosis (Cadenas, Buckingham 
et al. 1999; Blanc, Alves-Guerra et al. 2003; Chan and Harper 2006). 
However, their impact on body metabolism remains poorly understood.  
 
1.4.1 Genetic manipulation of UCP-2 and -3 
Early work looking at over-expression of UCP-2 (Fleury, 
Neverova et al. 1997) and UCP-3 (Gong, He et al. 1997) in yeast and 
mammalian cell lines showed marked mitochondrial uncoupling with 
lowered Δψm. However, over-expression of UCP mRNA (up to 66-fold), 
resulting in very high levels of protein, can significantly impact upon the 
integrity and structure of the inner mitochondrial membrane, resulting in 
an artefactual increase in proton conductance (Stuart, Harper et al. 2001; 
Cadenas, Echtay et al. 2002).  
Studies using UCP-2 and -3 knockout mice are inconsistent 
(Nedergaard and Cannon 2003)). Reduced proton leak was found in 
thymocytes of Ucp2(-/-) mice (Krauss, Zhang et al. 2002), and skeletal 
muscle from Ucp3(-/-) mice (Vidal-Puig, Grujic et al. 2000). There was a 
concomitant increase in skeletal muscle ATP synthesis in-vivo in Ucp3(-/-) 
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mice (Cline, Vidal-Puig et al. 2001). However, Cadenas et al (Cadenas, 
Echtay et al. 2002) showed no changes in O2 consumption rates, 
respiratory control ratios or proton conductance in muscle mitochondria. 
Of note, this study was carried out using backcrossed mice (Nedergaard 
and Cannon 2003).Neither Ucp2(-/-) nor Ucp3(-/-) mice showed distinct 
phenotypes compared to wild-type counterparts in terms of total body 
energy metabolism, weight regulation, exercise tolerance, fatty acid 
oxidation and cold-induced thermogenesis (Arsenijevic, Onuma et al. 
2000; Gong, Monemdjou et al. 2000; Vidal-Puig, Grujic et al. 2000).  
 
1.4.2 UCPs and ROS production 
Macrophages isolated from Ucp2(-/-) mice exposed to Toxoplasma 
gondii produced more ROS while the mice had lower levels of 
inflammation and infection than their wild-type counterparts (Arsenijevic, 
Onuma et al. 2000). Vidal-Puig et al (Vidal-Puig, Grujic et al. 2000) 
reported higher ROS production in skeletal muscle mitochondria of Ucp3(-
/-) mice. Mitochondrial uncoupling leads to a higher flux of electrons 
through the respiratory chain, resulting in diminished ROS production 
(Korshunov, Korkina et al. 1998). In Ucp3(-/-) mice, the lack of UCP-3 
protein should therefore result in lower uncoupled respiration, but with 
increased ROS production (Vidal-Puig, Grujic et al. 2000).  
UCP-2 and -3 attenuate mitochondrial ROS production by “mild-
uncoupling” of oxidative phosphorylation in a negative feed-back loop [Fig 
1.6]  (reviewed in (Brand and Esteves 2005; Echtay 2007)). Proton leak in 
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rodent skeletal muscle mitochondria stimulated by superoxide or 4-
hydroxynonenol (product of lipid peroxidation) (Echtay, Roussel et al. 
2002; Aguirre and Cadenas 2010) was higher in mitochondria taken from 
starved rats and LPS-treated mice, where UCP-3 protein abundance was 
increased. No proton leak was inducible in mitochondria from Ucp3(-/-) 
mice while the addition of ROS scavengers such as superoxide 
dismutase and the UCP inhibitor, GDP (guanosine diphosphate) reversed 
the leak. Under physiological stress, inhibition of the electron transport 
chain leads to excess ROS production. ROS and its byproducts stimulate 
UCP activation leading to mild uncoupling of oxidative phosphorylation, 
with increased flux through the respiratory chain and reduction in 
transmembrane potential. These changes ultimately result in attenuation 
of ROS production. 
This mechanism is not universally accepted. Johnson-Cadwell et al 
(Johnson-Cadwell, Jekabsons et al. 2007) used the protonophore, 
carbonyl-cyanide-p-trifluoromethoxyphenyl hydrazone (FCCP), to mildly 
uncouple neuronal mitochondria. The cells had been stressed by 
glutamate and exhibited increased mitochondrial ROS production. 
Addition of FCCP to mildly uncouple the mitochondria (<10mV reduction 
in Δψm) resulted in little change in mitochondrial matrix ROS production 
but did diminish spare respiratory capacity with a detrimental effect on 
cell survival. In another study, starvation induced a five-fold rise in rat 
skeletal muscle UCP-2 and -3 mRNA and UCP-3 protein levels, yet no 
changes were noted in muscle mitochondrial proton leak (Cadenas, 
Buckingham et al. 1999). These results imply that UCP -2 and -3 do not 
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catalyse proton leak, or that they must be activated before they do so.   
 
Figure 1.6 Proposed “mild uncoupling” function of UCP-2 and -3 
activated by superoxide or a lipid peroxidation by-product. Mild 
uncoupling leads to a reduction in transmembrane potential, thereby 
reducing availability of unpaired electrons of the respiratory chain to 
interact with O2 to produce superoxide. This negative feed-back loop 
limits mitochondrial superoxide production. 
 
Through their presumed function as mitochondrial uncoupling 
proteins, UCP-2 and 3 may play significant roles in non-shivering 
thermogenesis (reviewed by (Bézaire, Seifert et al. 2007)). However, 
compared to wild-type mice, no differences in core body temperature or 
metabolic response were found in Ucp3(-/-) mice in response to cold 
exposure (Vidal-Puig, Grujic et al. 2000), nor by injection of tri-
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iodothyronine or a selective β3-agonist into wild-type mice (both potent 
stimulators of uncoupling proteins) (Gong, Monemdjou et al. 2000). Cold 
exposure of arctic ground squirrels increased UCP-1 expression and 
protein abundance, but did not impact on UCP-3 expression (Barger, 
Barnes et al. 2006). Ucp1(-/-) mice are cold-sensitive yet their adipose 
tissue had no thermogenic properties, even though UCP-2 and -3 were 
still expressed (Enerbäck, Jacobsson et al. 1997). Under extreme 
adrenergic stimulation, such as hyperthermia induced by excess amounts 
of MDMA (3,4-methylenedioxymethylamphetamine), UCP-3 had a 
thermogenic role that was absent in Ucp3(-/-) mice (Mills, Banks et al. 
2003; Mills, Rusyniak et al. 2004). 
UCP-2 regulates insulin production through alterations in coupling 
efficiency of oxidative phosphorylation and ROS production (Affourtit, 
Jastroch et al. 2011). Increasing glucose levels results in a higher 
ATP/ADP ratio through oxidative phosphorylation in the pancreatic beta 
cells. This leads to closure of plasma membrane KATP channels with 
depolarisation resulting in release of insulin (Rutter 2001). Acute knock-
down of UCP-2 in INS-1 cells produced more insulin through more 
efficient oxidative phosphorylation. While this effect is apparent in cell 
models of glucose-stimulated insulin release, it is more discrepant in 
Ucp2(-/-) mice, likely due to metabolic adaptations and ROS damage 
(Affourtit and Brand 2008; Affourtit, Jastroch et al. 2011).  
 UCP-3 is involved in fatty acid metabolism (reviewed by (Brand 
and Esteves 2005; Bézaire, Seifert et al. 2007). UCP-3 expression is up-
regulated in the presence of increased levels of fatty acids, e.g. 
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starvation. UCP-3 may transport excess fatty acids out of the 
mitochondrial matrix, thereby reducing potential toxicity from this 
accumulation. No such changes have been seen in Ucp3(-/-) mice. More 
controversially, UCPs have been implicated as a mitochondrial Ca2+ 
uniporter (Trenker, Malli et al. 2007), although this is heavily disputed 
(Brookes, Parker et al. 2008). 
In summary, the functional roles of UCP-2 and -3 are still not 
clearly understood. The most convincing evidence to date supports their 
role in attenuating mitochondrial ROS production, though their role in total 
body metabolism is likely to be minimal, at least in physiological states.  
 
1.4.3 UCP-2 and -3 in sepsis  
Sepsis is associated with significant increases in ROS production. 
According to the mild uncoupling theory, activation of UCPs by ROS 
results in mild uncoupling of electron transport from ATP production. This 
produces a modest degree of mitochondrial depolarisation, reducing ROS 
production while theoretically sustaining ATP production (Brand and 
Esteves 2005). 
Of note, rats given endotoxin showed a three-fold increase in 
hepatocyte UCP-2 expression (mRNA and protein), and a reduction in 
Δψm (Růzicka, Skobisová et al. 2005). Increased UCP-2 expression was 
also reported in liver, white adipose tissue, skeletal and cardiac muscle 
(Faggioni, Shigenaga et al. 1998; Yu, Barger et al. 2000; Roshon, Kline et 
al. 2003). UCP-3 expression rose in skeletal muscle after 16-24 hrs of 
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sepsis (Faggioni, Shigenaga et al. 1998; Yu, Barger et al. 2000; Roshon, 
Kline et al. 2003; Sun, Wray et al. 2003). Faecal peritonitis in rats 
produced a 52% rise in myocardial UCP-2 mRNA abundance in cardiac 
muscle homogenates yet the actual protein was undetectable in 
mitochondria isolated from these hearts. This  led to the conclusion that 
UCP-2 has no role in septic myocardial dysfunction (Roshon, Kline et al. 
2003). A separate study involving LPS injection into young mice showed 
a five-fold rise in skeletal muscle UCP-3 expression while liver UCP-2 
mRNA abundance dropped five-fold. Despite rises in UCP-3 expression, 
core temperature dropped to a nadir of 30°C (Yu, Barger et al. 2000). 
Compared to control mice no difference in proton leak kinetics of the 
mitochondrial isolated from liver and muscle were noted  
The physiological response to sepsis has yet to be reported in 
Ucp(-/-) mice. It is unclear whether increased UCP expression in sepsis 
could be adaptive or maladaptive. Activation of UCPs could play a 
protective role by decreasing Δψm, resulting in decreased ROS 
production. It may also have a profound effect on mitochondrial Ca2+ 
accumulation that depends on Δψm. It is equally plausible that increased 
UCP expression may decrease mitochondrial efficiency and ATP 
production, contributing further to the bioenergetic failure.   
 
1.5 Skeletal muscle function in sepsis 
Muscle weakness in the critically ill is a heterogeneous group of 
neuro-muscular disorders that is associated particularly with SIRS, sepsis 
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and multi-organ dysfunction (reviewed by (Deem, Lee et al. 2003; 
Hermans, De Jonghe et al. 2008)). A recent meta-analysis reported a 
46% prevalence of critical illness polyneuropathy and myopathy (CIPNM) 
in patients who required prolonged mechanical ventilation (Stevens, 
Dowdy et al. 2007). CIPNM may be a neuromuscular manifestation of 
MOF with the same underlying pathophysiology, though other factors 
such as length of mechanical ventilation (Levine, Nguyen et al. 2008; 
Hermans, Agten et al. 2010), glycaemic control (van den Berghe, 
Wouters et al. 2001), and use of steroids and neuromuscular blocking 
agents may also contribute to its development and severity (Garnacho-
Montero, Madrazo-Osuna et al. 2001; De Jonghe, Sharshar et al. 2002). 
CIPNM is associated with significant prolongation of weaning from 
mechanical ventilation (De Jonghe, Bastuji-Garin et al. 2007; Hermans, 
Wilmer et al. 2007). 
Severe sepsis with worsening multi-organ failure (SOFA scores 
≥10) is associated with reduced muscle force generation (Eikermann, 
Koch et al. 2006).  The maximum force of contraction was half to one 
third of the evoked muscle force in healthy volunteers who had 
undergone a two-week period of limb immobilization. Interestingly, 
unloading the diaphragm and peripheral muscles during mechanical 
ventilation, as well as starvation alone, result in respiratory (Lewis and 
Sieck 1990; Levine, Nguyen et al. 2008) and peripheral muscle atrophy 
(Le Bourdelles, Viires et al. 1994). However, this did not result in reduced 
force generation. Muscle atrophy is commonly seen in sepsis, but does 
not account for all the changes seen in muscle function. 
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1.5.1 Mechanism of septic skeletal muscle dysfunction    
Fatigue and decreased muscle strength of the diaphragm and 
respiratory muscles were first described in spontaneously breathing dogs 
and ventilated rats made endotoxaemic (Hussain, Simkus et al. 1985; 
Leon, Boczkowski et al. 1992). This was subsequently confirmed in other 
septic models (e.g. (Boczkowski, Vicaut et al. 1992; Supinski, Nethery et 
al. 1996; Fujimura, Sumita et al. 2000) and ICU patients (Cohen, 
Zagelbaum et al. 1982). Mechanisms underlying septic muscle 
dysfunction are multi-factorial and summarized in Figure 1.7 (reviewed by 
(Lanone, Taillé et al. 2005; Callahan and Supinski 2009). Increases in 
circulating pro-inflammatory cytokines are amplified in skeletal muscle 
tissue leading to increased production of ROS and RNS, and alterations 
in protein turnover and proteolysis (Wilcox, Osborne et al. 1992; Wilcox, 
Milliken et al. 1996). These changes are coupled with microcirculatory 
abnormalities (Boczkowski, Vicaut et al. 1992), and early reductions in 
tissue pO2 that recover later in the course of sepsis (Dyson, Bezemer et 
al. 2011). Production of reactive species are associated with alterations in 
protein function (Nethery, DiMarco et al. 1999; Callahan, Stofan et al. 
2001), reduced sensitivity of the contractile apparatus to Ca2+ as well as 
sarcolemmal damage, altered membrane excitability and sodium channel 
abnormalities ((Lin, Ebihara et al. 1998; Rossignol, Gueret et al. 2007), 
review by (Lanone, Taillé et al. 2005)). 
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Figure 1.7  The pathophysiology of septic muscle dysfunction is multi-
factorial. Increased cytokine levels, early tissue hypoxia and increased 
ROS/RNS production are likely orchestrators.  Contractile dysfunction 
results from altered protein metabolism and gene expression, 
bioenergetic dysfunction, sarcolemmal injury, altered ion channel activity 
and Ca2+ dysregulation.  
 
1.5.2 Inracellular Ca2+ in septic muscle dysfunction 
Few studies have investigated skeletal muscle Ca2+ signaling in 
sepsis. Calcium is a vital part of excitation-contraction coupling. Plasma 
membrane depolarisation at the start of muscle contraction results in an 
influx of Ca2+. This leads to further large release of Ca2+ from the 
sarcoplasmic reticulum (SR) [cellular Ca2+ stores] in a process termed 
Ca2+-induced Ca2+ release. This is stimulated through ryanodine 
receptors present on the SR. Released Ca2+ causes conformational 
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changes in the actin and myosin filaments resulting in muscle contraction. 
Contraction is terminated by the re-uptake of intracellular Ca2+ by the SR 
through an energy-dependent ionic pump, the sarco-endoplasmic  
reticulum Ca2+ ATPase (SERCA) [see review by (Berchtold, Brinkmeier et 
al. 2000)].  
Regulation of Ca2+ homeostasis in muscle contraction is vital, 
however relevant studies in sepsis are scanty and inconclusive. Benson 
et al (Benson, Hasselgren et al. 1989) described higher skeletal muscle 
cell Ca2+ levels in sepsis. Reduced re-uptake of Ca2+ and higher SR Ca2+ 
leak were reported in hearts of endotoxin-treated rats, leading to 
mitochondrial Ca2+ overload and resultant metabolic failure (Hassoun, 
Marechal et al. 2008). Diaphragms isolated from endotoxic mice showed 
reduced peak tension development to both Ca2+ and ryanodine 
stimulation, implying an abnormal Ca2+ response at the SR (Liu, Lai et al. 
2002). SR Ca2+ release is sensitive to NO (Mészáros, Minarovic et al. 
1996), so this may be a further potential mechanism affecting SR function 
in sepsis. Furthermore, reduced sensitivity of the contractile apparatus, 
again as a consequence of reactive species damage, may also contribute 
to changes in Ca2+ signaling (Supinski, Nethery et al. 2000). Interestingly, 
Zink et al (Zink, Kaess et al. 2008) described reduction in Ca2+ release by 
the SR of skeletal muscle isolated from septic mice. However, contrary to 
other studies, they reported an increase in contractile apparatus 
sensitivity to Ca2+. 
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1.5.3 Muscle fatigue in sepsis  
Respiratory muscle fatigue (decreased force/power generation 
during or after prolonged or repeated stimulation of muscle contraction 
(Place, Yamada et al. 2010)) likely contributes to respiratory failure in 
sepsis (Hussain 1998). In rodent models of sepsis, repeated phrenic 
nerve stimulation resulted in decreasing force of diaphragm muscle 
contraction with prolonged relaxation time, but preserved electrical 
activity (Lanone, Taillé et al. 2005). 
In vitro muscle fatigue occurs in a characteristic triphasic pattern 
(Figure 1.8). Four potential mechanisms have been proposed (reviewed 
by (Place, Yamada et al. 2010)): 
• extracellular K+ accumulation 
• muscle acidosis and increasing lactate accumulation 
• increasing Pi concentration  
• increased ROS/RNO production  
Skinned muscle fibre experiments showed that both extracellular 
K+ accumulation and increased lactate levels have minimal contributions 
to muscle fatigue (except at lower temperatures) (Zhang, Bruton et al. 
2006; Allen, Lamb et al. 2008). Intracellular acidosis is thought to affect 
the rate of force relaxation (Westerblad, Bruton et al. 1997). Energy for 
muscle contraction is derived from breakdown of ATP to ADP and 
inorganic phosphate (ATP  ADP + Pi). With repeated contraction, [ATP] 
is maintained by breakdown of phosphocreatine to creatine (PCr + ADP 
 ATP + Cr), and the reaction of two ADP molecules to form ATP and 
AMP (2ADP  ATP + AMP) (Allen, Lamb et al. 2008). This results in a 
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net reduction in [PCr], but a rise in [Cr] and [Pi]. The rising [Pi] is thought 
to enter the SR and precipitate with Ca2+, thereby reducing [Ca2+]i and 
resulting in a reduced force of contraction (Fryer, Owen et al. 1995; 
Westerblad and Allen 1996). Mitochondrial recruitment serves to maintain 
ATP levels, but even this is exhausted with continuing stimulation. In 
exercise, increased ROS levels have both a time-dependent and 
concentration effect on myofibrillar Ca2+ sensitivity leading to 
development of fatigue (Andrade, Reid et al. 2001).  
Fredriksson et al (Fredriksson, Hammarqvist et al. 2006) showed 
reduced levels of PCr and ATP and an increased lactate concentration in 
leg muscles of patients with sepsis. Lower ATP levels in skeletal muscle 
of severe septic patients were associated with reduced mitochondrial 
complex I activity and worse outcomes (Brealey, Brand et al. 2002). 
Depletion of reduced glutathione (antioxidant mechanism) and higher 
nitrite/nitrate levels signify increased reactive species production 
(Brealey, Brand et al. 2002; Brealey, Karyampudi et al. 2004). This is 
supported by studies showing higher cellular markers of ROS damage 
(Callahan, Stofan et al. 2001), (Andrades, Ritter et al. 2011), and that 
administration of intracellular anti-oxidants can prevent contractile and 
mitochondrial dysfunction (Dare, Phillips et al. 2009).  
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Figure 1.8 The characteristic triphasic pattern of muscle fatigue seen in 
this force trace of repeated tetanic stimulation (350 ms) of mouse flexor 
digitorum brevis (A). A rapid decline in force generation is accompanied 
by increased [Ca2+]i in phase 1. This likely represents rapid use of stored 
ATP and PCr. Force generation then reaches the plateau phase 2 where 
oxidative phosphorylation is recruited. This phase is shortened by 
mitochondrial inhibition following addition of cyanide (B), or in hypoxic 
conditions. Reduction in [Ca2+]i as a result of increasing inorganic 
phosphate (Pi) concentration and Ca2+-Pi precipitation in the SR, as well 
as reduced myofibrillar Ca2+ sensitivity rapidly deceases force generation 
in phase 3. (Figure from (Lännergren and Westerblad 1991)). 
 
1.6 Animal models of septic organ failure 
To investigate the pathophysiology of sepsis and novel therapeutic 
strategies, numerous animal models have been developed. However, 
there are substantial differences in physiological responses, not only 
between animal and human, but also between different investigators 
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using similar models. This might explain why many therapeutic agents 
that showed promise in animal models subsequently proved ineffective or 
even harmful in humans (reviewed by (Buras, Holzmann et al. 2005)). 
Rodent models are by far the most studied, but no standardized model of 
disease has been established that accurately reproduces the relevant 
physiological changes seen in patients with sepsis (Piper, Cook et al. 
1996).  
Hollenberg et al (Hollenberg, Dumasius et al. 2001; Hollenberg 
2005) described a caecal ligation and puncture (CLP) model of mouse 
faecal peritonitis where aggressive fluid resuscitation (50ml/kg of 0.9% 
saline s/c 6 hourly) and antibiotic therapy reproduced the classic 
hyperdynamic state seen in human sepsis and improved 48-hour survival 
(46% vs. 0% in untreated animals). Miyaji et al (Miyaji, Hu et al. 2003) 
also used fluid and antibiotics to improve early survival in aged mice 
undergoing CLP. Their fluid regimen was less aggressive but they did 
also show biochemical and histological evidence of organ failure.  
Few animal studies of sepsis have measured markers of organ 
dysfunction, attempted fluid resuscitation or stratified animals by the 
clinical severity of illness. My host lab developed an awake, long-term 
model of faecal peritonitis (Brealey, Karyampudi et al. 2004) in which rats 
were resuscitated with i/v fluids delivered continuously via an internal 
jugular vein catheter.  Animals were stratified by severity of illness using 
easily measureable clinical parameters, with the severely ill animals 
displaying biochemical evidence of MOF. Importantly, no antibiotics were 
used in this model as antibiotics can alter mitochondrial protein synthesis 
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and transport processes (Zhang, Ging et al. 2005; McKee, Ferguson et 
al. 2006; Duewelhenke, Krut et al. 2007).  
Physiological changes seen in animal models of sepsis are also 
influenced by the animal species, age, sex, co-morbidities, and type and 
severity of the insult (reviewed by (Dyson and Singer 2009)). Rodents are 
more resistant to LPS than larger animals and humans. LPS models have 
therefore been criticized as the higher doses used in rodents may 
produce toxic effects other than their immunostimulatory effects (Piper, 
Cook et al. 1996). CLP and live bacteria models produce severe forms of 
sepsis and more closely mimic “real life” polymicrobial sepsis.   
The incidence of sepsis increases with age, peaking at 65 years in 
large American and European studies (Angus, Linde-Zwirble et al. 2001; 
Padkin, Goldfrad et al. 2003). This is equivalent to an age of 18 months in 
mice (Turnbull, Wlzorek et al. 2003). Similar to humans, older rodents are 
more susceptible to the effects of endotoxin (Tateda, Matsumoto et al. 
1996) or polymicrobial sepsis (Turnbull, Wlzorek et al. 2003). However, 
due to cost constraints, most rodent studies of sepsis are performed in 
younger animals. Likewise, the incidence and outcomes from sepsis are 
also worse in males as a result of immunoregulation by oestrogen in the 
female sex (Diodato, Knöferl et al. 2001).  
In summary, establishing a sepsis model identical to the human 
form of the disease is difficult and a degree of compromise is necessary. 
It is also important to consider the factors discussed above that can 
potentially influence the results.   
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1.7 Project aims 
Sepsis is associated with significant changes in whole body 
metabolism, and with mitochondrial pathology. This has been proposed 
as an important pathophysiological mechanism underlying MOF. Most 
supporting data are from heterogenous models of disease, using 
mitochondrial preparations or whole tissue homogenates where the 
interdependence of mitochondrial function on cytoplasmic substrate 
supply and cellular ATP demand are disrupted. The aim of my thesis was 
to study mitochondrial function in an intact cellular environment within 
living tissues freshly isolated from septic animals. I placed particular 
emphasis on measuring mitochondrial transmembrane potential through 
novel fluorescent live-cell imaging techniques. 
I felt it was important to first establish and optimize a reproducible 
mouse model of sepsis. This required characterization of the septic insult, 
fluid resuscitation regimen and measurement of organ dysfunction and 
physiological changes that occur from induction of sepsis through to 
death or resolution. By using more robust work-loop stimulation/relaxation 
cycles that mimic in-vivo muscle activity, diaphragm muscle force, power 
generation and fatigue was studied. A significant amount of time was also 
dedicated to developing methods to study [Ca2+]i and [Ca2+]m using live-
cell fluorescent imaging.  
Little is known about the dynamics of oxidative phosphorylation 
and proton leak in sepsis. UCP-3 is upregulated in sepsis, but the cellular 
and metabolic consequences are poorly understood. No studies have 
incorporated Ucp-3(-/-) mice. Increased UCP-3 expression may be 
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adaptive, limiting ROS production, or maladaptive resulting in partial 
dissipation of Δψm (through mild uncoupling and increased proton leak) 
when mitochondrial capacity is already critical. Therefore, the impact of 
UCP-3 deletion on survival from sepsis, as well as cardiovascular, 
metabolic and muscle dysfunction were also investigated. Proton leak 
kinetics and mitochondrial ROS production were also measured in 
isolated mitochondria and compared to naïve and sham mice. 
 
 61 
CHAPTER 2. MURINE MODEL OF SEPSIS 
 
2.1 Introduction 
Rodent models are routinely used to investigate both the patho-
physiology of sepsis and novel therapeutic strategies. They attempt to 
mimic the human condition, yet significant differences are seen in 
physiological responses (Buras, Holzmann et al. 2005). Nevertheless, 
mouse models of sepsis have gained increasing favour due to transgenic 
technologies that allow manipulation of the genotype to test whole animal 
and cellular responses to the absence or over-expression of specific 
proteins (Haouzi 2011).  
My host lab previously developed an awake, long-term (3-day) rat 
model of faecal peritonitis (Brealey, Brand et al. 2002) whereby animals 
were resuscitated aggressively with continuous intravenous fluid infused 
via a cannula inserted into the internal jugular vein. Severely affected 
animals showed biochemical evidence of organ failure. A similar model 
had been developed in C57 black mice, but had not been fully evaluated 
and optimized. In particular, the mouse model needed to be reproducible 
(to reduce number of animals used), develop septic multi-organ failure, 
and allow easy severity stratification using clinical signs. 
 I used this model to carry out a top-down examination of whole 
animal, tissue and cellular metabolism in sepsis, and to investigate the 
impact of an absence of UCP3 protein. Although the metabolic response 
to sepsis induced by bacterial peritonitis or endotoxin have been reported 
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in mice (Yu, Barger et al. 2000; Leon 2004; Valencia, Sarma et al. 2005), 
no descriptions have been made in conjunction with multi-organ failure, 
cardiac dysfunction or after standard therapies such as fluid resuscitation. 
Furthermore, development of hypothermia in septic mouse models is 
known to depend on ambient temperature (Rudaya, Steiner et al. 2005), 
yet it is unclear how ambient temperature or correction of body 
temperature affects the whole body metabolic rate. 
In this chapter, whole animal metabolic changes in sepsis and 
starvation are described and correlated with changes in core temperature 
(before and after artificial re-warming to normal physiological levels), as 
well as changes in cardiovascular performance that affect tissue oxygen 
delivery. Cardiovascular reflexes were dynamically tested using fluid 
boluses to further define septic myocardial dysfunction to facilitate future 
studies using this model. These studies were carried out in wild-type C57 
black mice and are compared to Ucp3(-/-) mice later in the thesis.  
 
2.2 Methods 
 
2.2.1 Animal model 
Experiments were performed in accordance with the Animals 
(Scientific Procedures) Act 1986 and approval from the local Ethics 
Committee. Male, 18-30 week old C57 black mice (Charles River, 
Margate, UK), weighing 25-35g, were housed with 12-hour light and dark 
cycles and full access to food (standard chow) and water. Room 
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temperature was controlled at 21°C. All mice underwent a 7 day period of 
acclimatization in the laboratory prior to start of experiments. 
 
2.2.1.1 General anaesthesia (GA) for procedures 
Mice were anaesthetized with isoflurane in an enclosed chamber, 
and transferred onto a heated mattress where anaesthesia was 
maintained with the mice breathing spontaneously through a facemask 
entrained with a mixture of air and isoflurane. This was achieved using a 
Tetratec Whisper® Air pump (Spectrum Brands, Cincinnati, Ohio, USA) 
set at 500ml/min connected to a Tec 3 Isoflurane vaporizer. The minimal 
depth of anaesthesia with mice breathing spontaneously but having lost 
withdrawal reflex to pain, was tailored to each mouse at each time-point.  
 
2.2.1.2 Original model of sepsis 
This model was based on the awake rat model where insertion of 
tunneled intravascular lines (carotid artery and internal jugular vein) was 
followed 24 hours later by injection of faecal slurry (Brealey, Karyampudi 
et al. 2004).  
Tunneled intravascular lines (PVC tubing 0.61mm outer diameter, 
0.28mm inner diameter, Tyco, Victoria, Australia) were inserted into the 
right internal jugular vein and left carotid arteries under aseptic conditions 
and general anaesthesia. The lines emerged from the nape of the neck 
and passed through a cylindrical tether that was stitched to the skin of the 
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back. The end of the tether was attached to a pulley system so the mice 
could freely move around their cage and gain access to food and water. 
Intravascular lines were kept patent by 0.1 ml/hr of heparinised 
saline (1 unit/ml). Blood pressure was continuously recorded using a 
pressure transducer. After 24 hours’ recovery, 0.5 ml of diluted rat faecal 
slurry (1:7 dilution with 0.9% saline) prepared fresh was injected 
intraperitoneally into the septic group. No injection was made in the sham 
group to avoid accidental bowel injury. Fluid resuscitation commenced 2 
hours after the i/p slurry injection with a 1:1 mix of 5% glucose and 6% 
hetastarch (Elohaes®, Fresenius-Kabi) at a rate of 0.3 ml/hr (10 ml/kg/hr). 
Glucose was added to the resuscitation fluid to avoid hypoglycaemia. At 
24h the rate of infusion was halved. A clinical severity score validated in 
rats (Brealey, Karyampudi et al. 2004) was used to classify severity 
(Table 1). 
A survival study carried out soon after development of this model 
revealed a very high mortality in the sham mice (33% mortality at 72 hrs 
[Fig 2.3]). This was felt due to the operative procedure to insert 
intravascular lines and perhaps stress related to being tethered, and 
prompted the development of a new model of sepsis. 
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Table 2.1 (A) Clinical signs used to assess severity of illness, and (B) the 
severity of illness score based on the sum of the individual clinical signs. 
2.2.1.3 New model of mouse faecal peritonitis 
The major change in the new model was the absence of tunneled 
intravascular lines, thereby removing the surgical insult, any post-
operative pain and discomfort from the tether. Fluid resuscitation was 
instead carried out using subcutaneous (s/c) fluid. Other changes were:  
• Injection of faecal slurry into the peritoneal cavity following 
direct visualisation of the abdominal musculature through a 
transverse skin incision under GA, ensured correct placement 
Clinical sign Possible score 
Hunched? 0-1 
Bloated? 0-1 
Mucky eyes? 0-1 
Lack of alertness? 0-2 
Lack of movement? 0-2 
Severity of sepsis Sum of clinical score 
Mild 0-2 
Moderate 3-4 
Severe 5-7 
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of slurry. Sham animals had the same incision and injected 
with 0.9% saline. Wound was closed by a single stitch.  
• 20ml/kg volume of i/p slurry (septic) or saline (sham).   
• Fluid resuscitation at end of set-up procedure with 10ml/kg of 
0.9% saline s/c.  
• Further s/c fluid resuscitation using boluses of 50ml/kg of pre-
warmed 5% glucose/0.81% saline at 6, 18, 30 and 42 h time-
points under brief general anaesthesia.  
The scoring system shown in Table 2.1 was used at 24h to define 
sepsis severity in each mouse. The score was evaluated against 
physiological and biochemical parameters described below. 
Weight was recorded at 0 and 24 h. Core temperature and blood 
sugars were measured at 0, 6, 18 and 24 h time-points, immediately after 
induction of brief general anaesthesia and just prior to injection of the s/c 
fluid boluses. A thermistor (Thermilinear®, Yellow Spring Instruments, 
Ohio, USA) placed rectally (with tip of probe 1cm from anus) and coupled 
to an Ohm-meter was used to measure core temperature. Serum glucose 
was measured from blood obtained from a tail-snip. The same tail-snip 
was used for serial sampling by removing surface clot and massaging 
blood from the wound. Blood sugar was measured by an Ascensia Elite 
blood glucose monitor and test strips (Bayer, Mishawaka, USA). The 
instrument was regularly calibrated using manufacturer’s instructions. 
At 24 h, a group of mice (sham, mild, moderate and severe septic) 
were culled and 0.4-1 ml blood obtained by cardiac puncture. A small 
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volume of the blood was heparinised for blood gas analysis (ABL-70 
analyzer, Radiometer, Copenhagen, Denmark). The remainder was 
allowed to clot for 10 mins. spun twice (1600g) to separate the serum and 
frozen at -20°C. Serum electrolytes, urea, creatinine, liver enzymes 
(alanine transaminase, aspartate transaminase, alkaline phsophatase), 
and albumin were measured by The Doctor’s Laboratory, London.   
 
2.2.2 Standardisation of the septic insult 
 Initial experiments with this model showed a wide weekly variation 
in septic response and survival. Faecal slurry comprises a range of 
pathogenic bacterial species that vary dependent on diet and bowel 
colonization. This may explain the weekly variation in response seen in 
the mice. Preparation of a fixed amount of live bacteria (evaluated by 
microbiological methods) represents a considerable logistic challenge. On 
the other hand, the caecal ligation and puncture model requires an 
additional operative procedure and introduces an ischaemic/infarcted 
tissue component to the septic insult.  
 To reduce the variability of the septic insult, I investigated the 
effect of freezing faecal slurry and defrosting at weekly intervals on the 
number and potency of the bacteria. I performed this study with help from 
Drs Sean Nair and Samantha Packer (Eastman Dental Institute, UCL). 
Two batches of slurry were prepared. One was diluted in 0.9% saline and 
the other in a mixture of saline and glycerol (20% final volume) as 
glycerol reduces damage to bacteria by the freeze-thaw process. These 
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batches were aliquoted into 1 ml cryotubes and stored at -80°C. Each 
week for five weeks, an aliquot from each batch was thawed. Half was 
plated on agar plates to quantify the viable anaerobic and aerobic 
bacterial populations. The other half was diluted further and injected 
intraperitoneally into two C57 black mice to test in vivo potency. Results 
(see 2.3.2) showed that bacterial numbers remained static yet the freeze-
thaw process reduced bacterial potency.  
 During these experiments, I noted a more uniform response when 
the faecal slurry was made fresh and under more stringent conditions 
(dilution and storage in the fridge for <24 hours). I/p injection under direct 
vision (described above) also produced less variability. 
 
2.2.3 Cardiac output measurement by echocardiography 
Echocardiography was performed at 0, 3, 6 and 24h post-induction 
of sepsis. Sham-operated animals were used as non-septic controls. The 
mice were anaesthetized with isoflurane while breathing spontaneously. 
Severely ill animals and humans have lower anaesthetic requirements 
(Gill, Martin et al. 1995; Allaouchiche, Duflo et al. 2001). Therefore, the 
percentage of isoflurane was appropriately adjusted to maintain the same 
degree of anaesthetic depth, judged by loss of withdrawal reflex to pain 
as the reference point.  
A 13MHz probe connected to a Vivid 7 echocardiography machine 
(GE Healthcare, Chalfont St.Giles, Bucks) was used to obtain a 
parasternal long axis view of the heart. Peak velocity (PV) and the 
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velocity time integral (VTI) were measured using pulsed wave Doppler in 
the ascending aorta proximal to branching of the major vessels (Fig. 2.1). 
The velocity time integral of the Doppler flow profile in the ascending 
aorta represents ‘stroke distance’ (SD), the distance a column of blood 
travels in the aorta during each systole (Fig. 2.13). Stroke volume is the 
product of stroke distance and aortic cross-sectional area. Aortic diameter 
was assumed to be 1.35mm, as measured in similar age and size mice 
using a 30MHz probe, (personal communication, Dr.Steve Hollenberg, 
Cooper Hospital, Camden, NJ, USA).  
The peak velocity (PV) is a marker of myocardial contractility 
assuming normal valve and vessel structure. It is the peak of the Doppler 
flow profile (Fig. 2.13). Both PV and VTI have been validated in an open-
chest mouse model (Hartley, Michael et al. 1995). Each measurement of 
PV and VTI was taken from the average of six Doppler envelopes. 
 Parasternal short axis views and M-mode echocardiograms of the 
left ventricle were obtained at the papillary muscle level to assess 
fractional shortening (Figs 2.12 & 2.13): 
Fractional shortening  =  End-diastolic diameter - end-systolic diameter 
              End-diastolic diameter 
 
Further experiments were performed to assess the response of the 
cardiovascular system to intravenous fluid boluses at 6h and 24h 
following induction of faecal peritonitis. Following general anaesthesia, 
the anterior skin of the neck was incised under aseptic conditions and the 
right internal jugular vein cannulated with PVC tubing (0.61mm outer 
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diameter x 0.28mm inner diameter, Tyco, Victoria, Australia). An Ultra-
Miniature Mikro-Tip Pressure Transducer Catheter (1FG; Millar 
Instruments, Houston, Texas, USA) was introduced into the left carotid 
artery for real-time measurement of blood pressure. Mice were warmed 
during instrumentation to achieve a core temperature of 34-36°C. 
Following a 10-minute period of stabilisation, a baseline 
echocardiogram was performed. Echocardiogram and blood pressure 
recordings were then made after serial fluid boluses of 0.5 ml of warmed 
hydroxyethyl starch solution (Voluven®, Fresenius Kabi, Germany) to a 
total of 3 ml. Each fluid bolus was administered over 3 minutes and 
echocardiogram performed immediately after each bolus. There was a 
10-minute gap between each fluid bolus. These experiments were 
performed rapidly to minimize the effect of dilutional anaemia. 
 
  
Figure 2.1 Parasternal long axis echocardiogram of the mouse heart with 
colour Doppler showing the aortic arch and left ventricle (LV). The dotted 
line is the orientation of the cursor of pulsed wave Doppler; the cosine 
rule was used to correct for the angle of flow. 
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2.2.4 Measurement of whole body metabolic rate 
  Whole body metabolic rates were measured by placing mice into 
sealed metabolic chambers (Oxymax system, Columbus Instruments, 
Columbus, OH, USA) for the duration of the experiment (Fig 2.2).  
 
Figure 2.2 (A) The Oxymax system shown with two rat metabolic carts 
on the right and the central controller and gas analyzer boxes on the left. 
(B) A metabolic cart with gas inflow (green line) and outflow at the top 
with water bottle inverted into the cage. The boxes are fully sealed and 
gas flow in and out is controlled by a central controller.  
 
The rig consisted of four chambers, allowing simultaneous 
recordings in four mice at any one time. Gas samples were analyzed from 
each box over a 90 second sampling period every 8 minutes. Oxygen 
consumption (VO2) and CO2 production (VCO2) were calculated by 
applying the Fick principle using the concentration of gas pumped in and 
out of the box over the sampling period: 
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VO2 = Vi O2i -Vo O2o (Vi and Vo are the input and output 
ventilation rates (LPM), O2i and O2o are 
oxygen fractions at the input and output) 
VCO2 = Vo CO2o -Vi CO2i (Vi and Vo are the input and output 
ventilation rates (LPM) CO2i and CO2o 
are carbon dioxide fractions at the input 
and output) 
The respiratory exchange ratio (RER) was calculated as 
VCO2/VO2. This ratio indicates the predominant fuel being used to 
provide energy at a given time. Values near 1 indicate a predominance of 
carbohydrate metabolism while values near 0.7 indicate fatty acid 
oxidation (Jéquier, Acheson et al. 1987). 
 
2.2.4.1 The effect of re-warming on metabolic rate in sepsis 
The effect of re-warming on total body metabolism was 
investigated by transferring the septic animals from their metabolic cages 
to a heated chamber (set to 38°C) for 1.5 hours. The animals were then 
quickly returned to their sealed boxes and recordings recommenced. 
Ideally, the re-warming should have occurred in the metabolic chamber, 
but this proved logistically and financially impossible.  
Re-warming took place at 10h and 24h when metabolic down-
regulation was fully established, and absorption of the subcutaneous 
fluids (injected at 6 and 18h) would have taken place. This reduced the 
risk of cardiovascular compromise upon re-warming. Echocardiograms 
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were performed to measure cardiac output before and after re-warming to 
assess changes in oxygen delivery (see later for detail). 
 
2.3 Results 
 
2.3.1 Survival in the original mouse model 
  Initial studies using the original model of sepsis were carried out 
using male 18-22 week old mice weighing 21-28 g. Experiments were 
performed in five batches spread over a two-week period with animals 
randomly allocated to sham and septic groups. 
 Mortality was 73% (8/11) in septic mice at 48 h (Fig. 2.3); most of 
the deaths occurring within 24 h. Crucially, there was a high mortality rate 
(33%) in the sham mice (3/9 dead), with signs of illness apparent in the 6 
surviving sham mice (severity scores of 2-3). This suggested that the 
instrumentation procedure and/or the fluid regimen were hazardous.  
 The intra-arterial lines regularly became blocked due to their small 
calibre, with only two reliable continuous arterial pressure recordings 
achieved in the sham group and one in the septic group.  No difference in 
mean arterial pressure (MAP) between the sham and septic recordings 
were found (both in the region of 100mmHg).  
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Figure 2.3 Kaplan-Meier survival curve of sham and septic animals in the 
tethered, i/v fluid-resuscitated original model of sepsis. Mice had 
tunnelled intravascular lines inserted at the -24h time-point and were 
allowed to recover before receiving i/p faecal slurry (septic) or saline 
(sham) at 0h. 
 
 Coincidental with this initial work, another study in the host lab 
using this model failed to detect biochemical evidence of organ failure, 
even in severely ill animals. All these features were dissimilar from the rat 
model where healthy, surviving sham animals and sick septic animals 
with organ dysfunction were reliably obtained. Possible explanations 
include operator technique and differences in animal phenotype. This 
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latter phenomenon had previously been witnessed within the laboratory 
when colonies from new breeding pairs were established.  
 Further experiments were thus essential to redesign and refine the 
model in order to achieve: 
i. healthy sham animals 
ii. biochemical and functional evidence of organ dysfunction in 
the septic animals 
iii. avoidance of intra-vascular lines as these yielded little useful 
data and the tether system in use at the time was unwieldy  
iv. standardization of the septic insult 
v. review of the fluid resuscitation regimen to prevent both 
hypovolaemia and potential volume overload  
 
2.3.2 New mouse model of sepsis 
 The new model had no intravascular lines inserted. Instead, fluid 
resuscitation was performed by serial subcutaneous injection of fluid 
along with other optimisation steps (described in more detail below).  
 To standardise the septic insult, faecal slurry was diluted in saline 
or saline plus 20% glycerol, and stored at -80°C. The number of viable 
bacteria in the 0.9% saline group decreased by two log orders over a 3-
week period, while the number of viable bacteria in 20% glycerol 
remained static, even after five weeks (Fig 2.4). However, despite this 
maintained viable bacterial count, in vivo testing indicated diminished 
potency over the five weeks (Table 2.2). This may be a direct result of 
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reduction in bacterial toxin titres with prolonged freezing (Freeman and 
Wilcox 2003).  
 Clearly, freezing faecal slurry was not a viable option. Instead, the 
following changes were made to the model: 
i. Fresh faecal slurry made weekly with stringent conditions;  
ii. Intraperitoneal injection of faecal slurry under direct vision; 
iii. Weight-adjusted volume of slurry (20ml/kg);  
iv. Subcutaneous fluid resuscitation regimen. 
These changes resulted in a more predictable model of disease resulting 
in a reduced number of mice used but favouring a more severe disease.  
 Laparotomies performed on the septic mice at 24h showed varying 
degrees of stomach and bowel dilatation, pus and adhesions depending 
on the severity of sepsis. These findings were likely due to paralytic ileus 
and gastric stasis caused by peritoneal inflammation and irritation.  
As close observation of feeding behaviour revealed that even the 
mildly septic animals stopped eating. Therefore, a new control group of 
starved sham mice was included where mice had access to water but not 
food following i/p injection of saline. 
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Figure 2.4 Aliquots of slurry stored in either 20% glycerol or 0.9% saline 
at -80°C and thawed weekly to measure viable bacterial count. 
 
 
No of Weeks 
stored 
Outcome Clinical severity score 
at 48hrs 
1 Mouse 1- dead (15 h) 
Mouse 2- dead (23 h) 
dead 
dead 
3 Mouse 1- survived 
Mouse 2- dead (36 h) 
2 
dead 
5 Mouse 1- survived 
Mouse 2- survived 
1 
0 
 
Table 2.2 Outcome of mice receiving i/p injection of slurry preserved in 
20% glycerol at -80°C. Severity score ≤2 mild, 3-4 moderate, ≥5 = severe 
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2.3.2.1 Serum biochemistry at 24 hours  
Following implementation of the above changes, blood samples 
were taken at 24h following induction of sepsis. These showed a graded 
rise in biochemical markers of renal and hepatic dysfunction with 
increasing severity of illness (Fig. 2.5): 
i. serum urea and creatinine rose significantly (4- and 8-fold rise, 
respectively) in the severely septic mice (p<0.05);  
ii. rise in liver transaminases (2-3 fold in severe mice, p<0.05); 
iii. serum albumin levels were reduced by up to 28% in all septic 
groups when compared to fed sham animals receiving 
equivalent amounts of fluid (p<0.05). 
 
2.3.2.2 Arterial blood gases at the 24h time-point 
 Table 2.3 shows blood gas sample analyses taken by direct 
cardiac puncture soon after anaesthesia. Depth of anaesthesia had been 
adjusted to account for degree of hypothermia and severity of illness. A 
mixed metabolic and respiratory acidosis was seen in the severely septic 
animals. Interestingly, even naïve mice had a low serum bicarbonate 
([HCO3-]  ~18 mmol/L) and high standard base deficits (-8 mmol/l). These 
findings persisted despite re-calibration of the analyser. Haemoglobin 
concentrations were higher in the severely septic mice, likely as a result 
of haemoconcentration due to capillary leak. 
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Figure 2.5 Serum urea, creatinine, aspartate transaminase (AST), 
alanine transferase (ALT) and albumin taken from sham (n=5), mild 
septic (n=5), moderate septic (n=6) and severe septic (n=6) mice at 24 h.    
§ p<0.05 when compared to sham and mild septic mice.   
* p<0.05 when compared to sham mice.  
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 Naive Fed Sham Starved 
Sham 
Fed 
Severe 
Starved 
Severe 
P 
value 
N 6 2 4 3 7  
pH 
 
7.31 ± 0.07 7.33 ± 0.01 7.34 ± 0.04 7.06 ± 0.06 
* 
6.91 ± 0.11 
* 
<0.05 
pCO2 
(kPa) 
4.86 ± 0.93 4.66 ± 0.01 4.04 ± 0.58 6.65 ± 0.37 
* 
9.23 ± 1.96 
* ‡ 
<0.05 
pO2 
(kPa) 
12.0 ± 3.2 14.0 ± 1.0 13.0 ± 5.9 14.4 ± 0.7 11.3 ± 5.0 NS 
HCO3-
(mmol/l) 
18.1 ± 2.0 18 ± 0 17.4 ± 0.5 14.1 ± 1.7 
* 
8.9 ± 2.1 
* ‡ 
<0.05 
BE 
(mmol/l) 
-7.7 ± 2.6 -8 ± 0.0 -8.8 ± 0.7 -16 ± 2.6 
* 
-18.8 ± 3.2 
* 
<0.05 
Lactate 
(mmol/l) 
5.6 ± 0.4  3.2 ± 0.4       
§ 
 4.5 ± 0.3        <0.05 
Hb 
(g/dl) 
13.3 ± 0.4 13.1 ± 0.3 13.2 ± 0.3 13.3 ± 1.1 15.9 ± 1.2 
* ‡ 
<0.05 
Na+ 
(mmol/l) 
147 ± 1  147 ± 3  147 ± 2 NS 
K+ 
(mmol/l) 
4.9 ± 0.6  4.3 ± 0.3  4.4 ± 0.7 NS 
Cl- 
(mmol/l) 
116 ± 2  123 ± 6 
* 
 122 ± 2 
* 
<0.05 
Table 2.3 Results of blood gas analysis by direct cardiac puncture at 24h 
in sham, septic and naïve mice. Results shown as mean ± standard 
deviation. Statistical analysis was performed using one way ANOVA.  
p<0.05 when compared to naïve, fed sham and starved sham.  
‡ p<0.05 when compared to fed severe septic.   
§ p<0.05 when compared to naïve and starved septic. 
BE= Base Excess, Hb= Haemoglobin. 
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2.3.2.3 Blood glucose changes over 24 hours 
 Blood samples taken at 0, 6,18 and 24 hours following induction of 
sepsis showed no evidence of hypoglycaemia in this model. The lowest 
values were recorded in the starved severe septic animals where, at 6h 
and 18h, blood sugars were 5.2 ± 1.0 and 5.8 ± 1.4 mmol/l, respectively 
(Fig 2.6). Blood sugar at the 0h time-point was high (12.2±0.3 mmol/L) 
and may reflect stress caused to mice as a result of general anaesthesia 
and tail snipping.  
 
 
 
Figure 2.6 Serum glucose in naïve, starved sham and starved severe 
septic animals over 24 hours. At 0h, i/p slurry was injected. A mixture of 
saline 0.81%/glucose 5% was injected s/c to all mice at 6h and 18h. 
Results are expressed as mean ± SD. There were 6, 4 and 8 mice in the 
naïve, starved sham and starved severe septic groups, respectively. 
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2.3.2.4 Effect of sepsis on body temperature in mice 
Rectal temperatures measured immediately after induction of 
anaesthesia and at 0, 6, 18 and 24h following injection of faecal slurry (or 
saline injection for sham animals) are shown in Fig. 2.7. All septic mice 
exhibited a drop in temperature at 6 hours which was much more 
pronounced in the severely ill animals (p<0.05), and lower still in those 
that were concurrently starved (p<0.05). 
  
 
Figure 2.7 Core temperatures of mice after injection of faecal slurry or 
saline at 0h. The number of mice per group is indicated in parentheses. 
Two-way ANOVA with Scheffe post-hoc analysis was used to describe 
the statistical relationship between the groups. 
* indicates p<0.05 when compared to all groups.  
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2.3.2.5 Weight changes following induction of sepsis  
As mentioned earlier, septic mice stopped eating. However, the 
severely septic mice actually gained weight over the 24 hours (weight 
gain of 4.2 ± 1.6% fed septic, 5.2 ± 0.8% starved septic) [Table 2.4]. Post-
mortems carried out in these mice showed significant amount of 
sequestered fluid in subcutaneous spaces, as well as peritoneal/pleural 
effusions and distended bowel filled with fluid.  
On the other hand, the mildly septic animals lost 6.2 ± 1.6% of 
their body weight and manifested little in the way of tissue oedema, 
ascites or pleural effusion fluid. Starvation in the sham animals led to a 
7.5 ± 1% weight reduction despite the subcutaneous fluid (Fig 2.8). Fed 
sham mice showed no statistical weight change (-1.8 ± 1.3%; p>0.05). 
 
 Weight   
0h (g) 
Weight  
24h (g) 
Change in 
weight (g) 
P 
value 
Fed Sham (7) 30.8 ± 1.2 30.2 ± 1.1 -0.6 ± 0.4 0.161 
Starved sham (10) 31.0 ± 1.1 28.7 ± 1.0 -2.4 ± 0.3 0.000 
Fed Mild Septic (9) 32.5 ± 0.9 30.4 ± 1.0 -2.0 ± 0.5 0.006 
Fed Severe Septic (9) 30.3 ± 0.9 31.6 ± 0.9 1.2 ± 0.4 0.018 
Starved Severe Septic (17) 31.5 ± 0.9 33.0 ± 1.0 1.6 ± 0.2 0.000  
Table 2.4 Weight of mice at induction of sepsis (Weight 0h) and 24 hours 
(Weight 24h) after i/p faecal slurry or saline. Statistical analysis was 
performed using a paired sample t-test.  
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Figure 2.8 Percentage change in body weight over 24 hours following i/p 
injection of faecal slurry or saline. 
§ p<0.05 compared to fed sham and severe septic groups; *p<0.05 
compared to fed sham, starved sham and mild septic (one way ANOVA).   
 
2.3.3 Cardiac output and peak aortic blood flow velocity decrease in 
severe sepsis 
Serial echocardiograms were performed at 0, 3, 6 and 24h to 
investigate cardiovascular responses to faecal peritonitis, and the 
adequacy of the subcutaneous fluid regimen. Sham animals required 
anaesthesia with 1.5-2% isoflurane, and severe septic mice only 0.5-1%. 
Fifteen sham and thirty septic mice were evaluated. Of the 30 
septic mice, eight developed mild sepsis, three moderate sepsis, and 13 
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severe sepsis. Six septic mice died before 24h. Demographic data were 
similar between groups (Table 2.5).  A survival curve is shown in Fig 2.9.  
Group Number Age (weeks) Weight (g) 
Sham  15 22.5 ± 0.7 31.3 ± 0.8 
Mild Septic  8 20.9 ± 0.9 32.8 ± 1.0 
Severe Septic  13 22.1 ± 0.7 30.9 ± 0.7 
Dead before 24h  6 23.6 ± 1.2 33.8 ± 1.2 
Table 2.5 Demographic data of mice that underwent serial 
echocardiography over 24h. One way ANOVA showed no significance. 
  
Figure 2.9 Kaplan-Meier survival curve of septic mice undergoing serial 
echocardiography over 72 hours following injection of faecal slurry i/p. 
 
 Fig. 2.10 shows haemodynamic measurements in sham and septic 
mice. As early as 3h there were profound changes in stroke volume and 
peak velocity in severely septic animals. These changes were more 
pronounced by 6h with a smaller left ventricular cavity indicative of 
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hypovolaemia (videos taken at various time-points are on supplemental 
CD). Heart rate was initially maintained at 3 hours, but then progressively 
declined, following the trend in body temperature (Fig 2.7). 
 By 24 hours, the LV cavity size had returned to the original 0h size 
(see videos), but peak velocity remained low, implying poor myocardial 
contractility. Stroke volume had partially recovered and, in conjunction 
with the falling heart rate, resulted in poor cardiac output.  
 
Figure 2.10 Aortic peak velocity (A), stroke volume (B), heart rate (C) and 
cardiac output (D) of sham, mild septic and severe septic mice at 0, 3, 6 
and 24h from i/p injection of faecal slurry or saline.  
P<0.005 two way ANOVA with repeated measures comparing the severe 
septic group to the mild septic and sham groups. 
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2.3.3.1 Cardiovascular response to intravenous fluid boluses in 
early severe sepsis is different to that seen in late severe sepsis. 
The above results suggest that early cardiovascular changes in 
severe sepsis are due mainly to hypovolaemia, while later changes may 
be due to a high afterload and myocardial dysfunction. In order to define 
and quantify the septic myocardial dysfunction, fluid responsiveness of 
the cardiovascular system was tested at 6 and 24h.  
 Boluses of fluids were delivered via the internal jugular cannula 
while continuously measuring BP. Echocardiograms were performed 
immediately post-insertion of catheters (baseline), and after cumulative 
totals of 0.5, 1, 1.5, 2, 2.5 & 3 ml of hetastarch had been injected. To 
remove the effect of hypothermia on cardiovascular function, the mice 
were warmed gently during the operative period using a warming 
mattress. All echocardiograms were performed with core temperatures 
>34°C. Operative time was approximately 30 mins. Fluid losses during 
this time (evaporative losses from open wound) were not replaced. 
Peak velocity, stroke volume and cardiac output of the severely 
septic mice were reduced at 6 and 24h compared to baseline values (Fig. 
2.11). Peak velocity fell to 68 ± 4% of baseline at 6h, and 63 ± 5% at 24h 
(p<0.05 two-way ANOVA). Stroke volume fell to 54 ± 3% of baseline at 
6h and 55 ± 6% at 24h (p<0.05). A non-significant rise in heart rate was 
noted at 6h but, at 24h, heart rate had fallen to 88 ± 6% of the baseline 
value (p<0.05, Wilcoxon signed-rank test). Cardiac output at 6h fell to 58 
± 4% of initial value, and to 48 ± 4% at 24h (p<0.05). 
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After two 0.5 ml fluid boluses, peak velocity, stroke volume and 
cardiac output increased in all groups (p<0.05) (Fig. 2.11). This was most 
marked in the 6h septic mice. A plateau was reached after 1.0 ml of fluid 
in all groups. No significant change was seen in heart rate of either sham 
or septic groups following the fluid boluses.  
The cardiovascular response to fluid in the 6h septic mice was 
homogenous and similar to sham mice (p>0.5) (Figs 2.11-2.13). The 
response in 24h septic mice was less marked (p<0.035 vs. sham and 6h 
septic mice). After 1.5 ml of cumulative fluid, the cardiovascular response 
of the 24h septic mice was heterogenous. Some maintained cardiac 
output with further fluid boluses, but others developed severe cardiac 
failure and died shortly after. The right ventricle (a difficult structure to 
visualise in mice) became prominent and dilated in the short axis view of 
the sickest mice (Fig 2.14). By contrast, sham and 6h septic mice could 
accommodate 3 ml of fluid without any reduction in cardiac output. 
Fig 2.15 shows changes in left ventricular end-diastolic and end-
systolic internal diameters at 6 and 24 h. Fractional shortening (a marker 
of myocardial contractility) was calculated using these diameters. There 
was no significant difference in initial (0h) diameters for the three groups 
(p=0.121). Septic groups showed a reduction in both diameters at 6 and 
24h (p<0.05, paired t-test), while sham mice diameters were unchanged. 
Following i/v boluses, end-systolic and end-diastolic diameters returned 
to their initial 0h values (p<0.05, repeated measures ANOVA). Fractional 
shortening increased at 6 and 24h in both septic groups (p<0.05, paired t-
test); after injection of IV fluid, this returned to initial 0h values.  
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Figure 2.15 Changes in end-systolic and end-diastolic diameters, and 
fractional shortening of sham and severe septic mice before and after 
fluid boluses. Echocardiograms were performed at 0h, and repeated at 
6h or 24h following vascular cannulation and injection of fluid boluses.  
* p<0.05 paired sample t-test comparing 0h to 6 and 24h in the septic 
groups.  
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2.3.4 Oxygen consumption (VO2) and carbon dioxide production 
(VCO2) in healthy fed and starved mice. 
Initial metabolic cage experiments were performed to obtain the 
metabolic rate in normal healthy mice, and to observe the impact of 
starvation. The mice adapted to their new environment in the metabolic 
cages within 2-3 hours. Therefore, all recordings were made after this 
period of acclimatisation. Fig 2.16 shows total body oxygen consumption 
(VO2) of two mice aged 22 weeks.  Diurnal variation in metabolic rate 
reflected nocturnal habits of rodents with increased VO2 and more 
frequent spikes of activity at night-time.  
 
 
Figure 2.16 Total body oxygen consumption of two C57 black mice under 
standard conditions, with free access to food and water. Three hours of 
acclimatisation was allowed prior to start of recordings. Each datapoint is 
the average of 4 recordings (8 mins apart) over 30 mins. 
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2.3.4.1 Metabolic rate, temperature and weight in starvation 
The effect of starvation on total body metabolism was observed in 
two separate experiments. In the first, six mice were placed into separate 
metabolic cages and, after an initial 4h period of acclimatisation, food was 
withdrawn but water was freely available. VO2 and VCO2 were measured 
over time. Food was re-introduced after 20 hours of starvation. 
Figure 2.17 shows that as starvation commenced, the VO2 
dropped to a nadir of 55 ± 5% of pre-starvation values at 10h (p=0.002) 
and remained low thereafter (67 ± 5% of baseline at 20h; p=0.021). VCO2 
followed the same pattern; being 50 ± 5% and 60 ± 5% of the starting 
values at 10h and 20h, respectively (p=0.005). Following re-introduction 
of food, VO2 and VCO2 increased significantly. The respiratory exchange 
ratio (RER) indicated a mix of fuel usage (RER=0.85) during the initial 
acclimatisation (Fig. 2.17). With the onset of starvation, RER dropped to 
0.72 ± 0.02 at 10h (p=0.032), implying a switch to predominantly fatty 
acid oxidation. Upon re-feeding, the ratio increased rapidly to 0.95 ± 0.03 
within 2h (p=0.000), indicating a switch back to carbohydrate metabolism. 
Despite the drop in metabolic rate with starvation, core 
temperature remained unchanged (Fig 2.18A). Body weight dropped by 
10% over the 24-hour period (from 28.5 ± 0.9g to 25.4 ± 0.8g at 20h; 
p<0.05) [Fig 2.18B].  
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Figure 2.17 Effect of starvation on VO2, VCO2 and respiratory exchange 
ratio (RER) in 6 healthy naïve mice. A 4-hour period of acclimatisation 
was allowed prior to withdrawal of food. Error bars represent SEM. 
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Figure 2.18 Change in VO2 with starvation plotted alongside core 
temperature (A) and body weight (B). Error bars=SEM. (n=4 animals) 
 
The second of these experiments investigated the effect of 
subcutaneous fluid given at 6h and 18h time-points on VO2, VCO2 and 
RER in sham fed and starved animals. The fluid boluses consisted of 5% 
dextrose in 0.81% saline and resulted in a short-lived (1.5 h) increase in 
VO2, VCO2 and RER in the starved mice, but no effect in the fed mice. 
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2.3.5 Whole body metabolic rate is reduced with severe sepsis 
Total body metabolism was measured after i/p faecal slurry or 
0.9% saline (sham). All mice received the standard fluid therapy regimen 
(saline 0.81%/ glucose 5%) at 0, 6 and 18h time-points. Mice were 
acclimatised in their metabolic cages for 3 h. All experiments were started 
at the same time of day to avoid bias due to diurnal variation in metabolic 
rate. Mice were allowed to recover for 1 h in a warm chamber prior to 
returning to their cages to the start of recordings.  
Six mice were in each sham group (fed or starved) and 13 in the 
septic group (all starved). Six developed mild sepsis and 7 became 
severely affected. Following induction of sepsis, there were early 
reductions in VO2 and VCO2 (Fig. 2.19), that increased in magnitude with 
disease severity (Table 2.6). The VO2 of severe septic mice reached a 
nadir of 468 ± 40 ml/kg/hr at 24h (20% of starting VO2; p<0.05). All these 
mice died within the next few hours. Interestingly, even at the 1h time-
point, the VO2 was significantly lower in the septic mice (Table 2.6).  
Similar reductions (and diurnal variation) in metabolic rate were 
seen in the mild septic and starved sham mice (Fig 2.19).  The VO2 of the 
mildly septic mice returned to baseline values after 16 h. This coincided 
with normalisation of temperature and an increased level of alertness and 
activity. However, RER remained between 0.7-0.8 as they were still 
starved. The RER in the starved sham and severe septic groups also 
remained between 0.7-0.8 throughout the 24h experimental period. In 
contrast, RER in sham fed mice was >0.9 from 6h onwards (Fig 2.19C). 
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A further feature in the septic mice was the loss of variability in 
VO2 and VCO2 compared to the sham animals (Fig 2.20). The sham mice 
characteristically displayed multiple spikes over a 1-hour period, whereas 
the septic mice lost their spike activity 3-4 hours post-injection of slurry. 
This was seen in both mild and severely septic mice, although some VO2 
spiking returned in the mildly septic mice after 12h. 
 
Group 1h VO2 
(ml/kg/hr) 
5h VO2 
(ml/kg/hr) 
10h VO2 
(ml/kg/hr) 
15h VO2 
(ml/kg/hr) 
20h VO2 
(ml/kg/hr) 
Fed Sham 3025 ± 156 2873 ± 337 2847 ± 178 2985 ± 282 2424 ± 152 
Starved 
Sham § 
3036 ± 138  1799 ± 150  2213 ± 91  2007 ± 271  1844 ± 146  
Mild Septic 
§ 
2619 ± 139 
‡ 
1829 ± 157  2091 ± 372  2038 ± 322  2494 ± 100  
Severe 
Septic * 
2341 ± 244 
‡  
1045 ± 293  827 ± 146  720 ± 146  550 ± 87   
Table 2.6 Whole body oxygen consumption (VO2) of sham and septic 
mice at 1, 5, 10, 15 and 20h post i/p saline (sham) or faecal slurry 
(septic). Values denote mean ± SEM. * p=0.000 two-way RM-ANOVA 
comparing severe septic group against all other groups. § p<0.04 two-
way RM-ANOVA comparing starved sham and mild septic series vs. fed 
sham and severe septic. ‡ p<0.05 significance when the 1h data of the 
septic animals is compared to the sham groups by ANOVA.  
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Figure 2.19 VO2 (A), VCO2 (B) and RER (C) of sham and septic mice.  
0h signifies the start of recordings 1-hour post injection of faecal slurry. 
Error bars = SEM. P<0.05 two-way RM-ANOVA comparing VO2 & VCO2 
of severe septic vs. other groups, and when comparing starved sham and 
mild septic with the fed sham group.  
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Figure 2.20 Trace of VO2 of a fed and a starved sham mouse (A), and a 
mild septic and a severely septic mouse (B) over a period of 24 h. The 
individual points are VO2 values taken at 8 min intervals. Sham animals 
display a high degree of variability between successive readings, 
whereas septic animals lose this variability within a few hours after 
induction of sepsis. 
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2.3.5.1 Relationship between temperature and VO2 
As the VO2 of severely septic mice fell, so did their core 
temperature (Fig 2.21). This is in contrast to starved sham mice where, 
despite a reduction in VO2 with starvation, no significant change in core 
temperature was seen (Fig 2.18A). Fig 2.22 summarises this finding in a 
plot of the VO2 against temperatures of septic and starved sham mice.  
 
 
Figure 2.21 VO2 and core temperature of mice after i/p injection of faecal 
slurry at time 0h (n=7). The mice displayed clinical signs of severe sepsis 
(scores of 5+). Core temperatures were measured at 0, 6, 18 and 24h. 
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Figure 2.22 Temperatures of starved sham (grey points) and severe 
septic (red points) mice taken at different time-points and plotted against 
their corresponding VO2 values. A curve of best fit has been drawn 
through the severe septic data. In the severe sepsis group, the points are 
generally concentrated at the top right of the graph at the beginning of the 
experiment (i.e. 0h and 6h) and shift to the bottom left with progression 
and worsening of the disease process (i.e. 18h and 24h). 
 
2.3.5.2 Effect of re-warming on VO2 and cardiac output in severe 
septic mice 
These studies were performed to investigate whether the reduction 
in VO2 in severe septic mice was due to hypothermia. Six severe septic 
mice were injected with i/p faecal slurry with five developing severe 
sepsis. They were re-warmed to 37°C at 10h and 24h time-points and 
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VO2 re-measured. All five mice survived to the 10h time-point but only 
three survived to 24h; a further mouse died during the re-warming 
process at 24h. Core temperatures were recorded before and after re-
warming, and prior to transfer back to their metabolic cages. Trans-
thoracic echocardiography was performed on three of the six mice at 
baseline (0h), pre-warming and post-warming at 10h and 24h time-points.  
Core temperatures reached a low of 29.8 ± 1.1°C at 10h, and 29.5 
± 1.3°C at 24h. Following 1.5 h of re-warming, temperatures increased to 
37.1 ± 1.2°C at 11.5h, and 36.7 ± 2.4°C at 25.5h [p<0.05] (Fig 2.23). 
Restoration of normal body temperature only led to a modest rise in VO2 
(from 925 ± 131 to 1190 ± 131 ml/kg/hr at 10h [p=0.007]; and from 730 ± 
90 to 941 ± 178 ml/kg/hr at 24h; [NS]). This modest rise occurred despite 
a 2-fold increase in cardiac output (from 9.7 ± 2.0 to 19.1 ± 2.7 ml/min 
post-warming at 10h [p=0.002], and from 15.8 ± 1.4 to 32.3 ± 9.2 ml/min 
after warming at 24h [NS]).  Statistical significance was not reached at 
the 24h time-point as only two mice survived to this stage. 
Once back in their metabolic cages, core temperature and VO2 fell 
rapidly back to pre-warming levels within 1.5 h (to 31.7 ± 1.4°C and 956 ± 
160 ml/kg/hr after the 10h re-warming episode; and to 29.4 ± 0.2°C and 
699 ±1 ml/kg/hr after the 24h re-warming episode).  
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Figure 2.23. VO2 and core temperature of mice with severe sepsis 
undergoing two episodes of warming over a 1.5 h time period (marked by 
the dashed lines). Mice were treated with s/c fluid boluses at 6 and 18h 
time-points. (Error bars are standard deviation).  
 
Table 2.7 and Fig. 2.24 summarize echo data. As shown before, 
peak velocity and stroke volume fell in line with temperature and 
metabolic rate at 10h and 24h. Cardiac output was reduced to one-third 
of baseline at 10h, and to half baseline at 24h (p<0.05).  
Following re-warming, there was a two-fold improvement in cardiac 
output. As sample size is small, these results should be treated with 
some caution however, even with three mice per group, the results 
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reached statistical significance at 10h, implying that hypothermia in 
severe sepsis has a profound effect on cardiovascular performance.  
  
10h re-warming 24h re-warming  Baseline 
Pre Post Pre Post 
Temperature 
(°C) 
36.1 ± 0.2 30.0 ± 1.5   
§ 
36.3 ± 0.6 * 28.8 ± 2.1   
§ 
36.6 ± 1.7 
VO2    
(ml/kg/hr) 
2288 ± 181 925 ± 131      
§ 
1190 ± 131 
* 
730 ± 90     
§  
941 ± 178 
Peak velocity 
(m/s) 
1.06 ± 0.06 0.46 ± 0.08 
§ 
0.80 ± 0.10 
* 
0.66 ± 0.07 
§ 
1.14 ± 0.13 
Heart rate 
(beats/min) 
509 ± 31 452 ± 23 601 ± 45 * 435 ± 6 614 ± 47 
Stroke volume 
(µl) 
60 ± 3 21 ± 3         
§ 
32 ± 6 * 36 ± 4         
§ 
52 ± 11  
Table 2.7 Temperature and echocardiography data from severe septic 
mice at baseline (0h), and pre- and post warming at 10h and 24h.  
Warming took place over 1.5 hours. Mice were only anaesthetized for the 
period of echocardiography. Values denote mean ± standard deviation. 
* p<0.05 paired t-test comparing post-warming values to their 
corresponding pre-warming value. § p<0.05 paired t-test comparing the 
values to corresponding baseline (0h) values.  
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Figure 2.24 Cardiac output at baseline (0h), pre-warming and post 
warming at 10h and 24h time-points. There was a two-fold increase in 
cardiac output following warming at the two time-points.  
* p<0.05 paired t-test comparing post-warming to pre-warming values.  
§ p<0.05 paired t-test comparing values to baseline values.   
 
 
2.4. Discussion 
 
2.4.1 Animal model of sepsis and in-vivo findings 
Mice are frequently used for lab models of sepsis because of their 
ready availability, relatively low costs and the ability to knock-in or knock-
out specific genes. In order to use animal models to understand disease 
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processes and to trial therapeutic options, it is vital to understand how the 
model behaves and whether or not it resembles the human form sepsis.  
I found the initial mouse model did not meet my requirements as 
instrumentation and connection to the tether system then in use was 
detrimental to their wellbeing. Indeed, only 67% of sham treated mice 
lived to 48h. Also as the intra-arterial line became obstructed frequently, I 
decided to simplify the model by no longer inserting vascular lines, and 
instead giving subcutaneous resuscitation fluid 6-12 hourly. To improve 
reproducibility, faecal slurry was injected i/p. under direct vision. 
I expended considerable effort in attempting to standardize the 
septic insult without the need for regular microbiological support (culturing 
and quantifying bacteria), and to achieve the severity of illness necessary 
for the experiments at the various time-points studied. I also tested 
different subcutaneous fluid resuscitation regimens, as previously 
described (Hollenberg, Dumasius et al. 2001; Miyaji, Hu et al. 2003). It 
was clearly important that the mice should develop organ failure as a 
result of sepsis yet, at the same time, avoiding cardiovascular collapse 
due to hypovolaemia caused by increased capillary leak and decreased 
fluid intake. Serum biochemistry demonstrated organ dysfunction in the 
severely ill animals while the sham and mild septic animals maintained 
normal vital organ function, at least within the parameters of the tests 
performed.  
Each mouse received 4 ml of fluid s/c over the 24h period. This is 
equivalent to twice their circulating volume (75ml/kg) and comparable to 
clinical practice in human sepsis where large volumes of fluids are 
 109 
required in the first 24-48 hours after the onset of sepsis (Rivers, Nguyen 
et al. 2001). 
This model generated a 100% sham animal survival and a 
divergent septic population. The host lab’s established clinical scoring 
system for rats was adopted for assessing sepsis severity in mice. This 
was found to be robust and correlated well with the biochemical markers 
of organ dysfunction where incremental rises were seen in serum urea, 
creatinine and liver function tests with increasing severity. The scoring 
system also correlated well with the blood gas data. Severely ill mice had 
a significantly lower blood pH that was of a mixed respiratory and 
metabolic nature. High arterial pCO2 values were likely to be as a result 
of lower lung compliance, respiratory muscle fatigue, heart failure (see 
later), and hypothermia affecting respiratory centre activity. As part of the 
inflammatory reaction, the diaphragm muscle of severely septic mice has 
been shown to generate less force than their naïve/sham counterparts 
with earlier fatigue (shown later in this thesis and (Supinski, Nethery et al. 
1996)). Furthermore, the pleural cavities of the severely septic mice were 
consistently found to be filled with straw-coloured effusion and their 
abdomen filled with pus and dilated loops of bowel. All of these findings 
are known to hinder diaphragmatic excursion and can lead to respiratory 
failure with a rising arterial pCO2. Despite this rise in arterial pCO2 and 
the likelihood of acute lung injury, no significant change was observed in 
arterial pO2. This (or even an increase) is also seen in rat models of 
shock and metabolic acidosis established within the lab, and implies that 
rodent lung physiology varies to some extent from the human response. 
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I was surprised to note acidaemia in the naïve and starved sham 
mice (base deficit of 7.7 ± 2.6 and 8.8 ± 0.7 mmol/l, respectively). These 
values are clearly higher than normal values of ±2 mmol/l seen in healthy 
humans and rats. The plasma bicarbonate levels were also low in the 
naïve and sham mice (18 ± 2 mmol/l), albeit these value are derived from 
the pH and PCO2 data. Other groups have also reported these findings in 
C57bl/6J mice (Henriksnäs, Phillipson et al. 2005; Sjöblom and Nylander 
2007). As metabolic acidosis was significantly worse in the severely 
septic mice (base deficit of 18.8 ± 3.3 mmol/l), I did not pursue this 
further. Similarly, I was surprised to note raised serum lactate levels in 
the healthy animals (e.g. 5.6 ± 0.4 mmol/l in the naïve mice) that did not 
increase markedly in the septic animals. Again, other researchers have 
reported similar elevations in healthy mice (Lewis, Haase et al. 2001; 
Hakimi, Yang et al. 2007), though others have noted values similar to 
normal humans and rats (Kao, Xenocostas et al. 2007; Kruse, Watt et al. 
2008). I re-tested the blood samples on an i-STAT® device (Abbott Labs, 
Chicago, IL, USA) and after obtaining similar results, decided not to use 
blood lactate as a marker of sepsis severity. 
Starvation had a profound effect on the body weight (7.7% 
reduction; p<0.05). This is likely to be mainly as a result of reduction in 
the fat stores, which have been shown to drop by one-third in a 14 hour 
non-feeding period (Bronson 1987). Septic mice in this model, exhibited a 
change in behaviour with a reduction in movement and anorexia. This 
was seen even in the mildly sick mice resulting in a significant weight loss 
from baseline levels (6.2% reduction; p<0.05). These behavioural 
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changes were more pronounced in severely ill animals, however, these 
mice gained weight (5% gain; p<0.05), most likely due to reduced s/c fluid 
absorption, reduced fluid clearance due to renal dysfunction, increased 
capillary leak, pleural/ascitic fluid and pus, and dilated fluid-filled loops of 
bowel.  
Only 10% of septic patients present with hypothermia (<35°C) 
(Clemmer, Fisher et al. 1992; Peres Bota, Lopes Ferreira et al. 2004). 
Interestingly, hypothermia is an independent predictor of mortality in 
sepsis (Arons, Wheeler et al. 1999; Peres Bota, Lopes Ferreira et al. 
2004). In my study, the septic mice became hypothermic and this was 
more profound in the severely ill animals. Other groups reported similar 
findings; for instance, (Yu, Barger et al. 2000) reported that core 
temperature in endotoxaemic mice fell to 30°C at 8h accompanied by a 
two-thirds reduction in basal metabolic rate. I too found an early fall in 
temperature occurring within a few hours of induction of sepsis that also 
correlated with the reduction in VO2. Even mildly septic mice exhibited a 
small decrease in core temperature by 6h, though this recovered by 18h. 
However, the severely ill animals remained hypothermic until 24h when 
the study was terminated. This hypothermic response was unrelated to 
the anorexic effect of sepsis as naïve fasting animals did not become 
hypothermic, although they did show a significant decrease in VO2 that 
was limited and normalized upon re-feeding.  
In the severely ill mice, a close correlation was found between VO2 
and body temperature. Thus, was the drop in temperature due to the fall 
in VO2, or vice versa? To answer these questions, the severely septic 
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animals were artificially warmed to 37°C at 10h and 24h. Despite an 
almost two-fold rise in cardiac output and hence oxygen delivery, there 
was only a small rise in VO2. These results imply that temperature had 
little effect on VO2 in severely septic mice, although it clearly influences 
cardiovascular function. 
 
Total daily energy expenditure is divided into resting metabolic rate 
(60-75%), diet-induced thermogenesis (10-15%) and the remainder as 
activity-related thermogenesis (Donahoo, Levine et al. 2004). There are 
additional effects on total energy expenditure in critically ill people related 
to the illness itself as a result of high levels of catecholamines and other 
stress hormones, as well as development of fever, agitation and 
increased respiratory workload (Chioléro, Revelly et al. 1997). Treatment 
strategies can also influence energy expenditure, so that sedative drugs 
and mechanical ventilation lead to a reduction and catecholamine 
infusions lead to an increase in total energy expenditure.  
Most human studies show maintained or slightly increased 
(approximately 15%) resting energy expenditure in severe sepsis 
(Kreymann, Grosser et al. 1993; Frankenfield, Wiles et al. 1994; Chioléro, 
Revelly et al. 1997) with extensive protein and fat catabolism, negative 
nitrogen balance and hyperglycaemia. Importantly, a negative correlation 
is seen with sepsis severity (Kreymann, Grosser et al. 1993). Healthy 
human volunteers given endotoxin showed a 2°C rise in temperature, a 
70% rise in oxygen delivery and a 40% rise in oxygen consumption after 
4h (Soop, Albert et al. 2004). By contrast, in my mouse model, metabolic 
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rate was consistently reduced within 4 h of sepsis and remained low in 
the severely sick animals. Together with the core temperature response, 
this represents an important species difference between mice and 
humans. This may represent an adaptive shutdown to an extrinsic insult 
akin to hibernation, or a direct pathological effect of systemic 
inflammation on metabolic processes and/or mitochondrial energy supply 
(Singer, De Santis et al. 2004; Levy 2007). Notably, this hypothermic 
response is not shared with rats who become pyrexic when septic, 
provided they receive adequate fluid (Brooks, Osabutey et al. 2007; 
Dyson, Stidwill et al. 2007).  
 
2.4.2 Cardiovascular response of mouse model of sepsis 
Echocardiography is a useful tool to investigate cardiovascular 
function in animal models of sepsis (Ullrich, Scherrer-Crosbie et al. 2000; 
Hollenberg, Dumasius et al. 2001; Merx, Liehn et al. 2005). Simultaneous 
echocardiography and pressure measurements allow detailed study of 
the cardiovascular response to sepsis, and can be used to prognosticate.  
Profound cardiovascular changes were seen within hours of 
induction of sepsis. In severely ill animals, aortic blood flow peak velocity 
(a marker of contractility) was almost halved at 6h and remained low at 
24h. Stroke volume and cardiac output data followed this pattern. Heart 
rate failed to increase, perhaps related to the concurrent hypothermia. 
The LV cavity was visibly smaller at 6h (LV end-diastolic and end-systolic 
diameters were half baseline values) and hyperdynamic. At 24h LV cavity 
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sizes were also smaller but to a lesser extent, and the LV was clearly less 
dynamic in function. Fluid challenges at 6h resulted in significant 
haemodynamic improvements, whereas at 24h, after initial improvement, 
caused deterioration presumably due to volume overload. This suggests 
that hypovolaemia is the predominant early cause of a low cardiac output, 
while reduced myocardial contractility is responsible later on. 
Septic myocardial dysfunction is characterized by reduced 
contractility, poor fluid responsiveness, and ventricular dilatation 
(Hollenberg, Dumasius et al. 2001; Zanotti-Cavazzoni, Guglielmi et al. 
2009). I found all of these changes in this mouse model of sepsis at 24h. 
However, in a fluid resuscitated and antibiotic treated CLP mouse model, 
sepsis was associated with increasing cardiac output and heart rate 
(Hollenberg, Dumasius et al. 2001). These mice received 50ml/kg fluid 
boluses every 6 h. But crucially, in this study the measured stroke 
volumes were 50% lower than those obtained in my study. This difference 
in stroke volume was likely related to the anaesthetic technique used. 
There is a large inter-individual variation in the minimum alveolar 
concentration (MAC) of inhalational anaesthetics (Sear 1992), particularly 
with concurrent hypothermia and sepsis (Gill, Martin et al. 1995; 
Allaouchiche, Duflo et al. 2001). I used the minimum concentration of 
isoflurane needed to maintain anaesthesia with loss of the withdrawal 
reflex to pinch as the endpoint for each mouse at different time-points. 
This fluctuated from 1.5-2% isoflurane in non-septic mice to only 0.5% in 
the severely septic animals. By contrast, Hollenberg et al (Hollenberg, 
Dumasius et al. 2001) used a large single dose of intramuscular 
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ketamine/acepromazine that provides rapid onset deep anaesthesia, but 
redistribution and excretion of the drugs results in a variable depth of 
anaesthesia. The cardiac depression and low stroke volume they 
recorded may be, at least in part, related to this anaesthetic regimen.  
The same group addressed this short-coming by using minimal 
concentrations of isoflurane during echocardiography (Zanotti-Cavazzoni, 
Guglielmi et al. 2009). In this latter study the effect on outcome from CLP-
induced sepsis of three different fluid regimens (low, intermediate and 
high volume) were compared. Their stroke volume and cardiac output 
changes were very similar to values I obtained, but baseline heart rate 
and the percentage fall at 24h was lower. They also found that stroke 
volume incrementally increased with increasing fluid resuscitation. A high 
volume s/c fluid resuscitation regimen (335 ml/kg over first 24 h) also 
improved 24h survival. This is however equivalent to 23.5 litres given to a 
70 kg patient over 24h, and nearly three-fold higher than the 130 
ml/kg/day I administered. This fluid was given subcutaneously and in my 
model of sepsis, was incompletely absorbed as some of this fluid 
persisted and could be seen at post-mortem.  
The pathophysiology of myocardial dysfunction in sepsis is multi-
factorial (Rudiger and Singer 2007). In my model, the hypothermia that 
occurred concurrently in the severely septic mice also had a significant 
impact on cardiovascular parameters. Apart from profound effects on 
heart rate, hypothermia is also thought to affect myocardial contractility 
and cardiac afterload (Greene, Cameron et al. 1989; Polderman 2009). 
This was apparent in the severely septic mice as cardiac output doubled 
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upon re-warming to 37°C due to significant increases in both heart rate 
and stroke volume.   
 
2.5 Conclusion 
I developed and characterized a long-term, fluid-resuscitated 
murine model of sepsis that I felt to be suitable for the further studies 
performed in this body of work. The model manifests biochemical 
evidence of organ dysfunction with a mixed metabolic and respiratory 
acidosis, the degree of which is related to both clinical severity and the 
fall in core temperature. Oxygen consumption is reduced in line with both 
clinical severity and the fall in body temperature. However, this does not 
improve on rewarming despite a two-fold increase in cardiac output, and 
is suggestive of a direct effect of systemic inflammation on decreasing 
cellular metabolism and/or energy supply. Despite fluid resuscitation, the 
fall in cardiac output during the initial phase of sepsis appears to be 
predominantly due to hypovolaemia, however, by 24h, myocardial 
depression and an autonomic response appears more important.  
Despite a similar infectious insult in mice of similar genotype, age, 
gender, food type and upbringing (often from the same litter), the septic 
phenotype varied markedly between animals. This indicates an important 
individual variation related to either transcriptional or post-transcriptional 
factors, and/or environmental influences such as previous exposure to 
infection. Mortality was related to the degree of clinical severity and could 
be prognosticated at an early stage in their septic process. 
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Although the septic phenotype does differ in some respects from 
that seen in the majority of septic patients, in particular the profound fall in 
temperature and oxygen consumption, many features are still shared. 
